Variants of SARS-CoV-2 explained

Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are viruses that, while similar to the original, have genetic changes that are of enough significance to lead virologists to label them separately. SARS-CoV-2 is the virus that causes coronavirus disease 2019 (COVID-19). Some have been stated, to be of particular importance due to their potential for increased transmissibility,[1] increased virulence, or reduced effectiveness of vaccines against them.[2] [3] These variants contribute to the continuation of the COVID-19 pandemic.

no variants are designated as circulating variants of concern by the World Health Organization.

Overview

The origin of SARS-CoV-2 has not been identified.[4] However, the emergence of SARS-CoV-2 may have resulted from recombination events between a bat SARS-like coronavirus and a pangolin coronavirus through cross-species transmission.[5] [6] The earliest available SARS-CoV-2 viral genomes were collected from patients in December 2019, and Chinese researchers compared these early genomes with bat and pangolin coronavirus strains to estimate the ancestral human coronavirus type; the identified ancestral genome type was labeled "S", and its dominant derived type was labeled "L" to reflect the mutant amino acid changes. Independently, Western researchers carried out similar analyses but labeled the ancestral type "A" and the derived type "B". The B-type mutated into further types including B.1, which is the ancestor of the major global variants of concern, labeled in 2021 by the WHO as alpha, beta, gamma, delta and omicron variants.[7] [8] [9]

Early in the pandemic, the relatively low number of infections (compared with later stages of the pandemic) resulted in fewer opportunities for mutation of the viral genome and, therefore, fewer opportunities for the occurrence of differentiated variants.[10] Since the occurrence of variants was rarer, the observation of S-protein mutations in the receptor-binding domain (RBD) region interacting with ACE2 was also not frequent.[11]

As time went on, the evolution of SARS-CoV-2's genome (by means of random mutations) led to mutant specimens of the virus (i.e., genetic variants), observed to be more transmissible, to be naturally selected. Notably, both the Alpha and the Delta variants were observed to be more transmissible than previously identified viral strains.[12]

Some SARS-CoV-2 variants are considered to be of concern as they maintain (or even increase) their replication fitness in the face of rising population immunity,[13] either by infection recovery or via vaccination. Some of the variants of concern show mutations in the RBD of the S-protein.[14]

The following table presents information and relative risk level[15] for currently and formerly circulating variants of concern (VOC). The intervals assume a 95% confidence or credibility level, unless otherwise stated. Currently, all estimates are approximations due to the limited availability of data for studies. For Alpha, Beta, Gamma and Delta, there is no change in test accuracy, and neutralising antibody activity is retained by some monoclonal antibodies.[16] PCR tests continue to detect the Omicron variant.

Nomenclature

SARS-CoV-2 corresponding nomenclatures[27]
PANGO lineagesNotes to PANGO lineagesNextstrain clades,[28] 2021GISAID cladesNotable variants
19BSContains "reference sequence" WIV04/2019
,,, L
V
20AGLineage B.1 in the PANGO Lineages nomenclature system; includes Delta/B.1.617[29] [30]
,,,, GH
20CIncludes Epsilon/B.1.427/B.1.429/CAL.20C and Eta/B.1.525[31]
20GPredominant in US generally, Feb '21
20HIncludes Beta/B.1.351 aka 20H/501Y.V2 or 501.V2 lineage
20BGRIncludes B.1.1.207 and Lambda (lineage C.37)[32]
20D
20JIncludes Gamma/P.1 and Zeta/P.2[33] [34]
20F
20IIncludes Alpha/B.1.1.7 aka VOC-202012/01, VOC-20DEC-01 or 20I/501Y.V1
B.1.17720E (EU1)[35] GVDerived from 20A
SARS-CoV-2 variants are grouped according to their lineage and component mutations. Many organisations, including governments and news outlets, referred colloquially to concerning variants by the country in which they were first identified.[36] [37] [38] After months of discussions, the World Health Organization announced Greek-letter names for important strains on 31 May 2021,[39] so they could be easily referred to in a simple, easy to say, and non-stigmatising fashion.[40] [41] This decision may have partially been taken because of criticism from governments on using country names to refer to variants of the virus; the WHO mentioned the potential for mentioning country names to cause stigma.[42] After using all the letters from Alpha to Mu (see below), in November 2021 the WHO skipped the next two letters of the Greek alphabet, Nu and Xi, and used Omicron, prompting speculation that Xi was skipped to avoid offending Chinese leader Xi Jinping. The WHO gave as the explanation that Nu is too easily confounded with "new" and Xi is a common last name.[43] In the event that the WHO uses the entirety of the Greek alphabet, the agency considered naming future variants after constellations.[44]

Lineages and clades

While there are many thousands of variants of SARS-CoV-2,[45] subtypes of the virus can be put into larger groupings such as lineages or clades. Three main, generally used nomenclatures have been proposed:

Each national public health institute may also institute its own nomenclature system for the purposes of tracking specific variants. For example, Public Health England designated each tracked variant by year, month and number in the format [YYYY] [MM]/[NN], prefixing 'VUI' or 'VOC' for a variant under investigation or a variant of concern respectively. This system has now been modified and now uses the format [YY] [MMM]-[NN], where the month is written out using a three-letter code.

Classification of variants

Variants that appear to meet one or more specific criteria considered during the COVID-19 pandemic may be labeled "variants of interest" or "variants under investigation" ('VUI') pending verification and validation of these properties. Once validated, variants of interest /VUI may be renamed "variants of concern" by monitoring organizations, such as the CDC in the US.[53] [54] A related category is "variant of high consequence", used by the CDC if there is clear evidence that the effectiveness of prevention or intervention measures for a particular variant is substantially reduced.[55]

Reference sequence

As it is currently not known when the index case or "patient zero" occurred, the choice of reference sequence for a given study is relatively arbitrary, with different notable research studies' choices varying as follows:

The variant first sampled and identified in Wuhan, China is considered by researchers to differ from the progenitor genome by three mutations.[61] [62] Subsequently, many distinct lineages of SARS-CoV-2 have evolved.[63]

Notability criteria

Viruses generally acquire mutations over time, giving rise to new variants. When a new variant appears to be growing in a population, it can be labelled as an "emerging variant". In the case of SARS-CoV-2, new lineages often differ from one another by just a few nucleotides.

Some of the potential consequences of emerging variants are the following:[64]

Variants that appear to meet one or more of these criteria may be labelled "variants under investigation" or "variants of interest" pending verification and validation of these properties. The primary characteristic of a variant of interest is that it shows evidence that demonstrates it is the cause of an increased proportion of cases or unique outbreak clusters; however, it must also have limited prevalence or expansion at national levels, or the classification would be elevated to a "variant of concern".[65] If there is clear evidence that the effectiveness of prevention or intervention measures for a particular variant is substantially reduced, that variant is termed a "variant of high consequence".

Variants of concern (WHO)

, the World Health Organization listed no variants of concern (VOC). Other organisations such as the CDC in the United States typically define their variants of concern slightly differently; for example, the CDC de-escalated the Delta variant on 14 April 2022, while the WHO did so on 7 June 2022. The WHO regularly publishes updates.

Overview of historical variants of concern or under monitoring

Omicron

See main article: SARS-CoV-2 Omicron variant.

Lineage B.1.1.529

The Omicron variant, known as lineage B.1.1.529, was declared a variant of concern by the World Health Organization on 26 November 2021.[66]

The variant has a large number of mutations, of which some are concerning. Some evidence shows that this variant has an increased risk of reinfection. Studies are underway to evaluate the exact impact on transmissibility, mortality, and other factors.[67]

Named Omicron by the WHO,[68] it was identified in November 2021 in Botswana and South Africa;[69] one case had travelled to Hong Kong,[70] [71] [72] one confirmed case was identified in Israel in a traveler returning from Malawi,[73] along with two who returned from South Africa and one from Madagascar.[74] Belgium confirmed the first detected case in Europe on 26 November 2021 in an individual who had returned from Egypt on 11 November.[75] Indian SARS-CoV-2 Genomics Consortium (INSACOG) in its January 2022 bulletin noted that Omicron is in community transmission in India where new cases have been rising exponentially.[76]

BA. sublineages

According to the WHO, BA.1, BA.1.1, and BA.2 were the most common sublineages of Omicron globally .[77] BA.2 contains 28 unique genetic changes, including four in its spike protein, compared to BA.1, which had already acquired 60 mutations since the ancestral Wuhan strain, including 32 in the spike protein.[78] BA.2 is more transmissible than BA.1.[79] It was causing most cases in England by mid-March 2022, and by the end of March, BA.2 became dominant in the US.[80], the sublineages BA.1 to BA.5 including all their descendants are classified as variants of concern by the WHO, the CDC, and the ECDC[81] (with the latter excluding BA.3).

Further sublineages emerging in 2022

During 2022, a number of further new strains emerged in different localities, including XBB.1.5, which evolved from the XBB strain of Omicron. The first case involving XBB in England was detected from a specimen sample taken on 10 September 2022 and further cases have since been identified in most English regions. By the end of the year, XBB.1.5 accounted for 40.5% of new cases across the US, and was the dominant strain; variant of concern BQ.1 was running at 18.3% and BQ.1.1 represented 26.9% of new cases, while the BA.5 strain was in decline, at 3.7%. At this stage, it was uncommon in many other countries, for example in the UK it was represented about 7% of new cases, according to UKHSA sequencing data.[82]

On 22 December 2022, the European Centre for Disease Control wrote in a summary that XBB strains accounted for circa 6.5% of new cases in five EU countries with sufficient volume of sequencing or genotyping to provide estimates.[82]

Further sublineages emerging in 2023: EG.5 "Eris", BA.2.86, and JN.1 "Pirola"

During 2023, SARS-CoV-2 continued to circulate in the global population and to evolve, with a number of new strains hitting the headlines. Testing, sequencing and reporting rates reduced.[83]

EG.5, a subvariant of XBB.1.9.2, (nicknamed "Eris" by some media[84]) emerged in February 2023.[85] On 6August 2023, the UK Health Security Agency reported the EG.5 strain was responsible for one in seven new cases in the UK during the third week of July.[86]

See main article: BA.2.86.

BA.2.86 was first detected in a sample from 24July 2023, and was designated as a variant under monitoring by the World Health Organization on 17 August 2023.[87]

JN.1 (sometimes referred to as "Pirola"), a subvariant of BA.2.86 Omicron, emerged during August 2023 in Luxembourg. By December 2023, it had been detected in 12 countries, including the UK and US.[88] [89] On 19 December, JN.1 was declared by the WHO to be a variant of interest independently of its parent strain BA.2.86, but overall risk for public health was determined as low.[90] With JN.1 accounting for some 60% of cases in Singapore, in December 2023, Singapore and Indonesia recommended wearing masks at airports.[91] The CDC estimated that the variant accounted for 44% of cases in the US on 22 December 2023 and 62% of cases on 5 January 2024.[92]

, JN.1 was estimated by the WHO to be the most prevalent variant of SARS-CoV-2 (70–90% prevalence in four out of six global regions; insufficient data in the East Mediterranean and African regions). The general level of population immunity and immunity from XBB.1.5 booster versions of the COVID-19 vaccine was expected to provide some protection (cross-reactivity) to JN.1.[93]

Further sublineages emerging in 2024: KP.1.1, KP.2 ("FLiRT"), KP.3 ("FLuQE")

Late in April 2024, CDC data showed KP.2 to be the most common U.S. variant, with a quarter of all cases, just ahead of JN.1. KP1.1 represented 7 percent of U.S. cases.[94] These two are known as FLiRT variants because they are characterized by a phenylalanine (F) to leucine (L) mutation and an arginine (R) to threonine (T) mutation in the virus's spike protein.[95] By July 2024, a descendant of FLiRT with an extra amino acid change in the spike protein, Q493E, was given the names KP.3 and FLuQE, and became a major variant in New South Wales during the Australian winter. Initial research suggested that the Q493E change could help FLuQE be more effective at binding to human cells than FLiRT.[96]

Omicron variants under monitoring (WHO, 2022/2023)

On 25 May 2022, the World Health Organization introduced a new category for potentially concerning sublineages of widespread variants of concern, initially called VOC lineages under monitoring (VOC-LUMs). This decision was made to reflect that in February 2022, over 98% of all GISAID sequenced samples belonged to the Omicron family, within which much of the variants' evolution took place. By 9 Februrary 2023, the category had been renamed as "Omicron variants under monitoring."

+ Pango lineageGISAID cladeNextstrain cladeRelation to circulating VOCsFirst documentedNotable features
BF.7GRA22BBA.5 sublineage2022-01-24BA.5 + S:R346T
BQ.1GRA22EBA.5 sublineage2022-02-07BQ.1 and BQ.1.1: BA.5 + S:R346T, S:K444T, S:N460K
BA.2.75GRA22DBA.2 sublineage2021-12-31BA.2.75: BA.2 + S:K147E, S:W152R, S:F157L, S:I210V, S:G257S, S:D339H, S:G446S, S:N460K, S:Q493R reversion
CH.1.1GRA22DBA.2 sublineage2022-07-20BA.2.75 + S:L452R, S:F486S
XBBGRA22FRecombinant of BA.2.10.1 and BA.2.75 sublineages, i.e. BJ1 and BM.1.1.1, with a breakpoint in S12022-08-13BA.2+ S:V83A, S:Y144-, S:H146Q, S:Q183E, S:V213E, S:G252V, S:G339H, S:R346T, S:L368I, S:V445P, S:G446S, S:N460K, S:F486S, S:F490S
XBB.1.5GRA23ARecombinant of BA.2.10.1 and BA.2.75 sublineages, i.e. BJ1 and BM.1.1.1, with a breakpoint in S12022-01-05XBB + S:F486P
XBFGRARecombinant of BA.5.2.3 and CJ.1 (BA.2.75.3 sublineage)2022-07-20BA.5 + S:K147E, S:W152R, S:F157L, S:I210V, S:G257S, S:G339H, S:R346T, S:G446S, S:N460K, S:F486P, S:F490S
JN.1GRA24ABA.2.86 sublineage; genetic features include S:L455S2023-08-25, classified as a VOI; "Omicron VOC" category no longer declared

Variants of interest (WHO)

Listed below are the Variants of Interest (VOI) which are recognised by the World Health Organization. Other organisations such as the CDC in the United States may at times use a slightly different list.

,[97] The WHO defines a VOI as a variant "with genetic changes that are predicted or known to affect virus characteristics such as transmissibility, virulence, antibody evasion, susceptibility to therapeutics and detectability" and that it is circulating more than other variants in over one WHO region to such an extent that a global public health risk can be suggested.[98] Furthermore, the update stated that "VOIs will be referred to using established scientific nomenclature systems such as those used by Nextstrain and Pango".

On 18 December 2023, the WHO listed XBB.1.5, XBB.1.16, EG.5, BA.2.86 and JN.1 as circulating variants of interest. Six months later,, the WHO listed only BA.2.86 and JN.1 as circulating variants of interest.

Variants under monitoring (WHO)

Listed below are Variants under Monitoring (VUM) which are recognised by the WHO. VUM's are defined as variants with genetic changes suspected to affect virus characteristics and some indication of posing a future risk, but with unclear evidence of phenotypic or epidemiological impact, requiring enhanced monitoring and repeat assessment after new evidence.

On 21 November 2023, the WHO listed DV.7, XBB in general, XBB.1.9.1, XBB.1.9.2, and XBB.2.3 as variants under monitoring., the WHO considered JN.1.7, KP.2, KP.3, JN.1.18, and LB.1 as variants under monitoring.

Previously circulating and formerly monitored variants (WHO)

The WHO defines a previously circulating variant as a variant that "has demonstrated to no longer pose a major added risk to global public health compared to other circulating SARS-CoV-2 variants", but should still be monitored.

On 15 March 2023, the WHO released an update on the tracking system of VOCs, announcing that only VOCs will be assigned Greek letters.

Previously circulating variants of concern (VOC)

The variants listed below had previously been designated as variants of concern, but were displaced by other variants., the WHO lists the following under "previously circulating variants of concern":

Alpha (lineage B.1.1.7)

See main article: SARS-CoV-2 Alpha variant.

First detected in October 2020 during the COVID-19 pandemic in the United Kingdom from a sample taken the previous month in Kent,[99] lineage B.1.1.7,[100] labelled Alpha variant by the WHO, was previously known as the first Variant Under Investigation in December 2020 (VUI – 202012/01)[101] and later notated as VOC-202012/01. It is also known as 20I (V1), 20I/501Y.V1 (formerly 20B/501Y.V1),[102] [103] or 501Y.V1.[104] From October to December 2020, its prevalence doubled every 6.5 days, the presumed generational interval.[105] [106] It is correlated with a significant increase in the rate of COVID-19 infection in United Kingdom, associated partly with the N501Y mutation. There was some evidence that this variant had 40–80% increased transmissibility (with most estimates lying around the middle to higher end of this range),[107] [108] and early analyses suggested an increase in lethality,[109] [110] though later work found no evidence of increased virulence.[111] As of May 2021, the Alpha variant had been detected in some 120 countries.[112]

On 16 March 2022, the WHO has de-escalated the Alpha variant and its subvariants to "previously circulating variants of concern".[113] [114]

B.1.1.7 with E484K

Variant of Concern 21FEB-02 (previously written as VOC-202102/02), described by Public Health England (PHE) as "B.1.1.7 with E484K" is of the same lineage in the Pango nomenclature system, but has an additional E484K mutation. As of 17 March 2021, there were 39 confirmed cases of VOC-21FEB-02 in the UK. On 4 March 2021, scientists reported B.1.1.7 with E484K mutations in the state of Oregon. In 13 test samples analysed, one had this combination, which appeared to have arisen spontaneously and locally, rather than being imported.[115] [116] [117] Other names for this variant include B.1.1.7+E484K[118] and B.1.1.7 Lineage with S:E484K.[119]

Beta (lineage B.1.351)

See main article: SARS-CoV-2 Beta variant.

On 18 December 2020, the 501.V2 variant, also known as 501.V2, 20H (V2), 20H/501Y.V2 (formerly 20C/501Y.V2), 501Y.V2,[120] VOC-20DEC-02 (formerly VOC-202012/02), or lineage B.1.351, was first detected in South Africa and reported by the country's health department.[121] It has been labelled as Beta variant by WHO. Researchers and officials reported that the prevalence of the variant was higher among young people with no underlying health conditions, and by comparison with other variants it is more frequently resulting in serious illness in those cases.[122] [123] The South African health department also indicated that the variant may be driving the second wave of the COVID-19 epidemic in the country due to the variant spreading at a more rapid pace than other earlier variants of the virus.

Scientists noted that the variant contains several mutations that allow it to attach more easily to human cells because of the following three mutations in the receptor-binding domain (RBD) in the spike glycoprotein of the virus: N501Y,[124] K417N, and E484K.[125] [126] The N501Y mutation has also been detected in the United Kingdom.[127]

On 16 March 2022, the WHO has de-escalated the Beta variant and its subvariants to "previously circulating variants of concern".

Gamma (lineage P.1)

See main article: SARS-CoV-2 Gamma variant.

The Gamma variant or lineage P.1, termed Variant of Concern 21JAN-02 (formerly VOC-202101/02) by Public Health England, 20J (V3) or 20J/501Y.V3 by Nextstrain, or just 501Y.V3, was detected in Tokyo on 6 January 2021 by the National Institute of Infectious Diseases (NIID). It has been labelled as Gamma variant by WHO. The new variant was first identified in four people who arrived in Tokyo having travelled from the Brazilian Amazonas state on 2 January 2021.[128] On 12 January 2021, the Brazil-UK CADDE Centre confirmed 13 local cases of the new Gamma variant in the Amazon rainforest.[129] This variant of SARS-CoV-2 has been named lineage P.1 (although it is a descendant of B.1.1.28, the name B.1.1.28.1[130] is not permitted and thus the resultant name is P.1), and has 17 unique amino acid changes, 10 of which in its spike protein, including the three concerning mutations: N501Y, E484K and K417T.[131] [132]

The N501Y and E484K mutations favour the formation of a stable RBD-hACE2 complex, thus, enhancing the binding affinity of RBD to hACE2. However, the K417T mutation disfavours complex formation between RBD and hACE2, which has been demonstrated to reduce the binding affinity.

The new variant was absent in samples collected from March to November 2020 in Manaus, Amazonas state, but it was detected for the same city in 42% of the samples from 15 to 23 December 2020, followed by 52.2% during 15–31 December and 85.4% during 1–9 January 2021. A study found that infections by Gamma can produce nearly ten times more viral load compared to persons infected by one of the other lineages identified in Brazil (B.1.1.28 or B.1.195). Gamma also showed 2.2 times higher transmissibility with the same ability to infect both adults and older persons, suggesting P.1 and P.1-like lineages are more successful at infecting younger humans irrespective of sex.[133]

A study of samples collected in Manaus between November 2020 and January 2021, indicated that the Gamma variant is 1.4–2.2 times more transmissible and was shown to be capable of evading 25–61% of inherited immunity from previous coronavirus diseases, leading to the possibility of reinfection after recovery from an earlier COVID-19 infection. As for the fatality ratio, infections by Gamma were also found to be 10–80% more lethal.[134] [135] [136]

A study found that people fully vaccinated with Pfizer or Moderna have significantly decreased neutralisation effect against Gamma, although the actual impact on the course of the disease is uncertain.A pre-print study by the Oswaldo Cruz Foundation published in early April found that the real-world performance of people with the initial dose of the Sinovac's Coronavac Vaccine had approximately 50% efficacy rate. They expected the efficacy to be higher after the 2nd dose. As of July 2021, the study is ongoing.[137]

Preliminary data from two studies indicate that the Oxford–AstraZeneca vaccine is effective against the Gamma variant, although the exact level of efficacy has not yet been released.[138] [139] Preliminary data from a study conducted by Instituto Butantan suggest that CoronaVac is effective against the Gamma variant as well, and as of July 2021 has yet to be expanded to obtain definitive data.[140]

On 16 March 2022, the WHO has de-escalated the Gamma variant and its subvariants to "previously circulating variants of concern".

Delta (lineage B.1.617.2)

See main article: SARS-CoV-2 Delta variant.

The Delta variant, also known as B.1.617.2, G/452R.V3, 21A or 21A/S:478K, was a globally dominant variant that spread to at least 185 countries.[141] It was first discovered in India. Descendant of lineage B.1.617, which also includes the Kappa variant under investigation, it was first discovered in October 2020 and has since spread internationally.[142] [143] [144] [145] [146] On 6 May 2021, British scientists declared B.1.617.2 (which notably lacks mutation at E484Q) as a "variant of concern", labelling it VOC-21APR-02, after they flagged evidence that it spreads more quickly than the original version of the virus and could spread quicker or as quickly as Alpha.[147] [148] [149] It carries L452R and P681R mutations in Spike; unlike Kappa it carries T478K but not E484Q.

On 3 June 2021, Public Health England reported that twelve of the 42 deaths from the Delta variant in England were among the fully vaccinated, and that it was spreading almost twice as fast as the Alpha variant.[150] Also on 11 June, Foothills Medical Centre in Calgary, Canada reported that half of their 22 cases of the Delta variant occurred among the fully vaccinated.[151]

In June 2021, reports began to appear of a variant of Delta with the K417N mutation.[152] The mutation, also present in the Beta and Gamma variants, raised concerns about the possibility of reduced effectiveness of vaccines and antibody treatments and increased risk of reinfection.[153] The variant, called "Delta with K417N" by Public Health England, includes two clades corresponding to the Pango lineages AY.1 and AY.2.[154] It has been nicknamed "Delta plus"[155] from "Delta plus K417N".[156] The name of the mutation, K417N, refers to an exchange whereby lysine (K) is replaced by asparagine (N) at position 417.[157] On 22 June, India's Ministry of Health and Family Welfare declared the "Delta plus" variant of COVID-19 a variant of concern, after 22 cases of the variant were reported in India.[158] After the announcement, leading virologists said there was insufficient data to support labelling the variant as a distinct variant of concern, pointing to the small number of patients studied.[159] In the UK in July 2021, AY.4.2 was identified. Alongside those previously mentioned it also gained the nickname 'Delta Plus', on the strength of its extra mutations, Y145H and A222V. These are not unique to it, but distinguish it from the original Delta variant.[160]

On 7 June 2022, the WHO has de-escalated the Delta variant and its subvariants to "previously circulating variants of concern".[161]

Previously circulating variants of interest (VOI)

Pango lineageGISAID cladeNextstrain cladeEarliest samplesDate of VOIDate of designationCountry of samplingNotes
P.2GR/484K.V220B/S.484K2020-042021-07-062021-08-17Zeta variant
P.3GR/1092K.V121E2021-012021-07-062021-08-17Theta variant
B.1.427
B.1.429		GH/452R.V121C2020-032021-07-062021-11-09Epsilon variant
B.1.617.1G/452R.V321B2020-102021-09-20Kappa variant
B.1.526GH/253G.V121F2020-112021-09-20Iota variant
B.1.525G/484K.V321D2020-122021-09-20Eta variant
C.37GR/452Q.V121G2020-122021-06-142022-03-09Lambda variant
B.1.621GH21H2021-012021-08-302022-03-09Mu variant

Epsilon (lineages B.1.429, B.1.427, CAL.20C)

See main article: SARS-CoV-2 Epsilon variant.

The Epsilon variant or lineage B.1.429, also known as CAL.20C[162] or CAVUI1,[163] 21C or 20C/S:452R, is defined by five distinct mutations (I4205V and D1183Y in the ORF1ab gene, and S13I, W152C, L452R in the spike protein's S-gene), of which the L452R (previously also detected in other unrelated lineages) was of particular concern.[164] From 17 March to 29 June 2021, the CDC listed B.1.429 and the related B.1.427 as "variants of concern".[165] [166] [167] As of July 2021, Epsilon is no longer considered a variant of interest by the WHO, as it was overtaken by Alpha.[168]

From September 2020 to January 2021, it was 19% to 24% more transmissible than earlier variants in California. Neutralisation against it by antibodies from natural infections and vaccinations was moderately reduced,[169] but it remained detectable in most diagnostic tests.[170]

Epsilon (CAL.20C) was first observed in July 2020 by researchers at the Cedars-Sinai Medical Center, California, in one of 1,230 virus samples collected in Los Angeles County since the start of the COVID-19 epidemic.[171] It was not detected again until September when it reappeared among samples in California, but numbers remained very low until November.[172] [173] In November 2020, the Epsilon variant accounted for 36 per cent of samples collected at Cedars-Sinai Medical Center, and by January 2021, the Epsilon variant accounted for 50 per cent of samples. In a joint press release by University of California, San Francisco, California Department of Public Health, and Santa Clara County Public Health Department,[174] the variant was also detected in multiple counties in Northern California. From November to December 2020, the frequency of the variant in sequenced cases from Northern California rose from 3% to 25%.[175] In a preprint, CAL.20C is described as belonging to clade 20C and contributing approximately 36% of samples, while an emerging variant from the 20G clade accounts for some 24% of the samples in a study focused on Southern California. Note, however, that in the US as a whole, the 20G clade predominates, as of January 2021. Following the increasing numbers of Epsilon in California, the variant has been detected at varying frequencies in most US states. Small numbers have been detected in other countries in North America, and in Europe, Asia and Australia. After an initial increase, its frequency rapidly dropped from February 2021 as it was being outcompeted by the more transmissible Alpha. In April, Epsilon remained relatively frequent in parts of northern California, but it had virtually disappeared from the south of the state and had never been able to establish a foothold elsewhere; only 3.2% of all cases in the United States were Epsilon, whereas more than two-thirds were Alpha.

Zeta (lineage P.2)

See main article: SARS-CoV-2 Zeta variant.

Zeta variant or lineage P.2, a sub-lineage of B.1.1.28 like Gamma (P.1), was first detected in circulation in the state of Rio de Janeiro; it harbours the E484K mutation, but not the N501Y and K417T mutations. It evolved independently in Rio de Janeiro without being directly related to the Gamma variant from Manaus. Though previously Zeta was labeled a variant of interest, as of July 2021, it is no longer considered as such by the WHO.

Eta (lineage B.1.525)

See main article: SARS-CoV-2 Eta variant.

The Eta variant or lineage B.1.525, also called VUI-21FEB-03 (previously VUI-202102/03) by Public Health England (PHE) and formerly known as UK1188, 21D or 20A/S:484K, does not carry the same N501Y mutation found in Alpha, Beta and Gamma, but carries the same E484K-mutation as found in the Gamma, Zeta, and Beta variants, and also carries the same ΔH69/ΔV70 deletion (a deletion of the amino acids histidine and valine in positions 69 and 70) as found in Alpha, N439K variant (B.1.141 and B.1.258) and Y453F variant (Cluster 5).[176] Eta differs from all other variants by having both the E484K-mutation and a new F888L mutation (a substitution of phenylalanine (F) with leucine (L) in the S2 domain of the spike protein). As of 5 March 2021, it had been detected in 23 countries.[177] [178] [179] It has also been reported in Mayotte, the overseas department/region of France. The first cases were detected in December 2020 in the UK and Nigeria, and as of 15 February 2021, it had occurred in the highest frequency among samples in the latter country. As of 24 February 56 cases were found in the UK. Denmark, which sequences all its COVID-19 cases, found 113 cases of this variant from 14 January to 21 February 2021, of which seven were directly related to foreign travel to Nigeria.

As of July 2021, UK experts are studying it to ascertain how much of a risk it could be. It is currently regarded as a "variant under investigation", but pending further study, it may become a "variant of concern". Ravi Gupta, from the University of Cambridge said in a BBC interview that lineage B.1.525 appeared to have "significant mutations" already seen in some of the other newer variants, which means their likely effect is to some extent more predictable.[180]

Theta (lineage P.3)

See main article: SARS-CoV-2 Theta variant.

On 18 February 2021, the Department of Health of the Philippines confirmed the detection of two mutations of COVID-19 in Central Visayas after samples from patients were sent to undergo genome sequencing. The mutations were later named as E484K and N501Y, which were detected in 37 out of 50 samples, with both mutations co-occurrent in 29 out of these.[181]

On 13 March, the Department of Health confirmed the mutations constitutes a variant which was designated as lineage P.3.[182] On the same day, it also confirmed the first COVID-19 case caused by the Gamma variant in the country. The Philippines had 98 cases of the Theta variant on 13 March.[183] On 12 March it was announced that Theta had also been detected in Japan.[184] [185] On 17 March, the United Kingdom confirmed its first two cases,[186] where PHE termed it VUI-21MAR-02.On 30 April 2021, Malaysia detected 8 cases of the Theta variant in Sarawak.[187]

As of July 2021, Theta is no longer considered a variant of interest by the WHO.

Iota (lineage B.1.526)

See main article: SARS-CoV-2 Iota variant.

In November 2020, a mutant variant was discovered in New York City, which was named lineage B.1.526.[188] As of 11 April 2021, the variant has been detected in at least 48 U.S. states and 18 countries. In a pattern mirroring Epsilon, Iota was initially able to reach relatively high levels in some states, but by May 2021 it was outcompeted by the more transmissible Delta and Alpha.

Kappa (lineage B.1.617.1)

See main article: SARS-CoV-2 Kappa variant.

The Kappa variant is one of the three sublineages of lineage B.1.617. It is also known as lineage B.1.617.1, 21B or 21A/S:154K, and was first detected in India in December 2020.[189] By the end of March 2021, Kappa accounted for more than half of the sequences being submitted from India.[190] On 1 April 2021, it was designated a variant under investigation (VUI-21APR-01) by Public Health England. It has the notable mutations L452R, E484Q, P681R.[191]

Lambda (lineage C.37)

See main article: SARS-CoV-2 Lambda variant.

The Lambda variant, also known as lineage C.37, was first detected in Peru in August 2020 and was designated by the WHO as a variant of interest on 14 June 2021. It spread to at least 30 countries[192] around the world and,, it is unknown whether it is more infectious and resistant to vaccines than other strains.[193] [194] On 16 March 2022, the WHO has de-escalated the Lambda variant to "previously circulating variants of concern".

Mu (lineage B.1.621)

See main article: SARS-CoV-2 Mu variant.

The Mu variant, also known as lineage B.1.621, was first detected in Colombia in January 2021 and was designated by the WHO as a variant of interest on 30 August 2021. There have been outbreaks in South America and Europe.[195] [196] On 16 March 2022, the WHO has de-escalated the Mu variant and its subvariants to "previously circulating variants of concern".

Formerly monitored variants (WHO)

The variants listed below were once listed under variants under monitoring, but were reclassified due to either no longer circulating at a significant level, not having had a significant impact on the situation, or scientific evidence of the variant not having concerning properties.

+ Pango lineageGISAID cladeNextstrain cladeEarliest samplesDate of VUMDate of designationCountry of sampling
AV.1GR2021-032021-05-262021-07-21
AT.1GR2021-012021-06-092021-07-21
R.1GR2021-012021-04-072021-11-09
B.1.466.2GH2020-112021-04-282021-11-09
B.1.1.519GR20B/S.732A2020-112021-06-022021-11-09Multiple countries
C.36.3GR2021-012021-06-162021-11-09Multiple countries
B.1.214.2G2020-112021-06-302021-11-09Multiple countries
B.1.1.523GR2020-052021-07-142021-11-09Multiple countries
B.1.619G2020-052021-07-142021-11-09Multiple countries
B.1.620G20A/S.126A2020-112021-07-142021-11-09
B.1.1.318AZ.5GR2021-012021-06-02
C.1.2GR2021-052021-09-01
B.1.630GH2021-032021-10-12
B.1.640GH/490R2021-092021-11-22
XD2022-012022-03-09 France

Other notable variants

Lineage B.1.1.207 was first sequenced in August 2020 in Nigeria;[197] the implications for transmission and virulence are unclear but it has been listed as an emerging variant by the US Centers for Disease Control. Sequenced by the African Centre of Excellence for Genomics of Infectious Diseases in Nigeria, this variant has a P681H mutation, shared in common with the Alpha variant. It shares no other mutations with the Alpha variant and as of late December 2020 this variant accounts for around 1% of viral genomes sequenced in Nigeria, though this may rise. As of May 2021, lineage B.1.1.207 has been detected in 10 countries.[198]

Lineage B.1.1.317, while not considered a variant of concern, is noteworthy in that Queensland Health forced 2 people undertaking hotel quarantine in Brisbane, Australia to undergo an additional 5 days' quarantine on top of the mandatory 14 days after it was confirmed they were infected with this variant.[199]

Lineage B.1.616, being identified in Brittany, Western France in early January 2021 and designated by WHO as "Variant under investigation" in March 2021, was reported to be difficult to detect from nasopharyngeal swab sampling method of coronavirus detection, and detection of the virus needs to rely on samples from lower respiratory tract.

Lineage B.1.618 was first isolated in October 2020. It has the E484K mutation in common with several other variants, and showed significant spread in April 2021 in West Bengal, India.[200] [201] As of 23 April 2021, the PANGOLIN database showed 135 sequences detected in India, with single-figure numbers in each of eight other countries worldwide.[202]

In July 2021, scientists reported in a preprint which was published in a journal in February 2022, the detection of anomalous unnamed unknown-host SARS-CoV-2 lineages via wastewater surveillance in New York City. They hypothesized that "these lineages are derived from unsampled human COVID-19 infections or that they indicate the presence of a non-human animal reservoir".[203] [204]

Lineage B.1.640.2 (also known as the IHU variant[205]) was detected in October 2021 by researchers at the Institut Hospitalo-Universitaire (IHU) in Marseille.[206] They found the variant in a traveler who returned to France from Cameroon and reportedly infected 12 people.[207] The B.1.640 lineage, which includes B.1.640.2, was designated a variant under monitoring (VUM) by the World Health Organization (WHO) on 22 November 2021.[208] However, the WHO has reported that lineage B.1.640.2 has spread much slower than the Omicron variant, and so is of relatively little concern.[209] According to a preprint study, lineage B.1.640.2 has two already known spike protein mutations – E484K and N501Y – among a total of 46 nucleotide substitutions and 37 deletions.[210] [211] [212]

In March 2022, researchers reported SARS-CoV-2 variant recombinant viruses that contain elements of Delta and Omicron – Deltacron (also called "Deltamicron").[213] [214] [215] [216] [217] Recombination occurs when a virus combines parts from a related virus with its genetic sequence as it assembles copies of itself. It is unclear whether Deltacron – which is not to be confused with "Deltacron" reported in January albeit the first detection was also in January[217] [218] – will be able to compete with Omicron and whether that would be detrimental to health.[219]

In July 2023, Professor Lawrence Young, a virologist at Warwick University announced a super mutated Delta variant from a swab of an Indonesian case with 113 unique mutations, with 37 affecting the spike protein.[220]

Notable missense mutations

There have been a number of missense mutations observed of SARS-CoV-2.

del 69-70

The name of the mutation, del 69-70, or 69-70 del, or other similar notations, refers to the deletion of amino acid at position 69 to 70. The mutation is found in the Alpha variant, and could lead to "spike gene target failure" and result in false negative result in PCR virus test.[221]

RSYLTPGD246-253N

Otherwise referred to as del 246-252, or other various similar expression, refer to the deletion of amino acid from the position of 246 to 252, in the N-terminal domain of spike protein, accompanied with a replacement of the aspartic acid (D) at the position 253 for asparagine (N).[222] [223]

The 7 amino acid deletion mutation is currently described as unique in the Lambda variant, and have been attributed to as one of the cause of the strain's increased capability to escape from neutralizing antibodies according to preprint paper.[224]

N440K

The name of the mutation, N440K, refers to an exchange whereby the asparagine (N) is replaced by lysine (K) at position 440.

This mutation has been observed in cell cultures to be 10 times more infective compared to the previously widespread A2a strain (A97V substitution in RdRP sequence) and 1000 times more in the lesser widespread A3i strain (D614G substitution in Spike and a and P323L substitution in RdRP).[225] It was involved in rapid surges of COVID-19 cases in India in May 2021.[226] India has the largest proportion of N440K mutated variants followed by the US and Germany.[227]

G446V

The name of the mutation, G446V, refers to an exchange whereby the glycine (G) is replaced by valine (V) at position 446.

The mutation, identified in Japan among inbound travelers starting from May, and among 33 samples from individuals related to 2020 Tokyo Olympic Games and 2020 Tokyo Paralympic Games, are said to be possible to impact affinity of multiple monoclonal antibody, although its clinical impact against the use of antibody medicine is still yet to be known.[228]

L452R

The name of the mutation, L452R, refers to an exchange whereby the leucine (L) is replaced by arginine (R) at position 452.

L452R is found in both the Delta and Kappa variants which first circulated in India, but have since spread around the world. L452R is a relevant mutation in this strain that enhances ACE2 receptor binding ability and can reduce vaccine-stimulated antibodies from attaching to this altered spike protein.

L452R, some studies show, could even make the coronavirus resistant to T cells, that are necessary to target and destroy virus-infected cells. They are different from antibodies that are useful in blocking coronavirus particles and preventing it from proliferating.

Y453F

The name of the mutation, Y453F, refers to an exchange whereby the tyrosine (Y) is replaced by phenylalanine (F) at position 453. The mutation have been found potentially linked to the spread of SARS-CoV-2 among minks in the Netherlands in 2020.[229]

S477G/N

A highly flexible region in the receptor binding domain (RBD) of SARS-CoV-2, starting from residue 475 and continuing up to residue 485, was identified using bioinformatics and statistical methods in several studies. The University of Graz[230] and the Biotech Company Innophore[231] have shown in a recent publication that structurally, the position S477 shows the highest flexibility among them.[232]

At the same time, S477 is hitherto the most frequently exchanged amino acid residue in the RBDs of SARS-CoV-2 mutants. By using molecular dynamics simulations of RBD during the binding process to hACE2, it has been shown that both S477G and S477N strengthen the binding of the SARS-COV-2 spike with the hACE2 receptor. The vaccine developer BioNTech[233] referenced this amino acid exchange as relevant regarding future vaccine design in a preprint published in February 2021.[234]

E484Q

The name of the mutation, E484Q, refers to an exchange whereby the glutamic acid (E) is replaced by glutamine (Q) at position 484.

The Kappa variant circulating in India has E484Q. These variants were initially (but misleadingly) referred to as a "double mutant".[235] E484Q may enhance ACE2 receptor binding ability, and may reduce vaccine-stimulated antibodies' ability to attach to this altered spike protein.

E484K

The name of the mutation, E484K, refers to an exchange whereby the glutamic acid (E) is replaced by lysine (K) at position 484.[236] It is nicknamed "Eeek".[237]

E484K has been reported to be an escape mutation (i.e., a mutation that improves a virus's ability to evade the host's immune system[238] [239]) from at least one form of monoclonal antibody against SARS-CoV-2, indicating there may be a "possible change in antigenicity".[240] The Gamma variant (lineage P.1), the Zeta variant (lineage P.2, also known as lineage B.1.1.28.2) and the Beta variant (501.V2) exhibit this mutation. A limited number of lineage B.1.1.7 genomes with E484K mutation have also been detected.[241] Monoclonal and serum-derived antibodies are reported to be from 10 to 60 times less effective in neutralising virus bearing the E484K mutation.[242] [243] On 2 February 2021, medical scientists in the United Kingdom reported the detection of E484K in 11 samples (out of 214,000 samples), a mutation that may compromise current vaccine effectiveness.[244] [245]

F490S

F490S denotes a change from phenylalanine (F) to serine (S) in amino-acid position 490.[246]

It is one of the mutation found in Lambda, and have been associated with reduced susceptibility to antibody generated by those who were infected with other strains, meaning antibody treatment against people infected with strains carrying such mutation would be less effective.[247]

N501Y

N501Y denotes a change from asparagine (N) to tyrosine (Y) in amino-acid position 501.[248] N501Y has been nicknamed "Nelly".

This change is believed by PHE to increase binding affinity because of its position inside the spike glycoprotein's receptor-binding domain, which binds ACE2 in human cells; data also support the hypothesis of increased binding affinity from this change. Molecular interaction modelling and the free energy of binding calculations has demonstrated that the mutation N501Y has the highest binding affinity in variants of concern RBD to hACE2. Variants with N501Y include Gamma, Alpha (VOC 20DEC-01), Beta, and COH.20G/501Y (identified in Columbus, Ohio). This last became the dominant form of the virus in Columbus in late December 2020 and January and appears to have evolved independently of other variants.[249] [250]

N501S

N501S denotes a change from asparagine (N) to serine (S) in amino-acid position 501.[251]

As of September 2021, there are 8 cases of patients around the world infected with Delta variant which feature this N501S mutation. As it is considered a mutation similar to N501Y, it is suspected to have similar characteristics as N501Y mutation, which is believed to increase the infectivity of the virus, however the exact effect is unknown yet.[252]

D614G

D614G is a missense mutation that affects the spike protein of SARS-CoV-2. From early appearances in Eastern China early in 2020, the frequency of this mutation in the global viral population increased early on during the pandemic.[253] G (glycine) quickly replaced D (aspartic acid) at position 614 in Europe, though more slowly in China and the rest of East Asia, supporting the hypothesis that G increased the transmission rate, which is consistent with higher viral titres and infectivity in vitro. Researchers with the PANGOLIN tool nicknamed this mutation "Doug".

In July 2020, it was reported that the more infectious D614G SARS-CoV-2 variant had become the dominant form in the pandemic.[254] [255] [256] [257] PHE confirmed that the D614G mutation had a "moderate effect on transmissibility" and was being tracked internationally.[258]

The global prevalence of D614G correlates with the prevalence of loss of smell (anosmia) as a symptom of COVID-19, possibly mediated by higher binding of the RBD to the ACE2 receptor or higher protein stability and hence higher infectivity of the olfactory epithelium.[259]

Variants containing the D614G mutation are found in the G clade by GISAID[260] and the B.1 clade by the PANGOLIN tool.

Q677P/H

The name of the mutation, Q677P/H, refers to an exchange whereby the glutamine (Q) is replaced by proline (P) or histidine (H) at position 677. There are several sub-lineages containing the Q677P mutation; six of these, which also contain various different combinations of other mutations, are referred to by names of birds. One of the earlier ones noticed for example is known as "Pelican," while the most common of these as of early 2021 was provisionally named "Robin 1."[261]

The mutation has been reported in multiple lineages circulating inside the United States as of late 2020 and also some lineages outside the country. 'Pelican' was first detected in Oregon, and as of early 2021 'Robin 1' was found often in the Midwestern United States, while another Q667H sub-lineage, 'Robin 2', was found mostly in the southeastern United States. The frequency of such mutation being recorded has increased from late 2020 to early 2021.[262]

P681H

The name of the mutation, P681H, refers to an exchange whereby the proline (P) is replaced by histidine (H) at position 681.

In January 2021, scientists reported in a preprint that the mutation P681H, a characteristic feature of the Alpha variant and lineage B.1.1.207 (identified in Nigeria), is showing a significant exponential increase in worldwide frequency, thus following a trend to be expected in the lower limb of the logistics curve. This may be compared with the trend of the now globally prevalent D614G.[263] [264]

P681R

The name of the mutation, P681R, refers to an exchange whereby the proline (P) is replaced by arginine (R) at position 681.

Indian SARS-CoV-2 Genomics Consortium (INSACOG) found that other than the two mutations E484Q and L452R, there is also a third significant mutation, P681R in lineage B.1.617. All three concerning mutations are on the spike protein, the operative part of the coronavirus that binds to receptor cells of the body.

A701V

According to initial media reports, the Malaysian Ministry of Health announced on 23 December 2020 that it had discovered a mutation in the SARS-CoV-2 genome which they designated as A701B(sic), among 60 samples collected from the Benteng Lahad Datu cluster in Sabah. The mutation was characterised as being similar to the one found recently at that time in South Africa, Australia, and the Netherlands, although it was uncertain if this mutation was more infectious or aggressive than before.[265] The provincial government of Sulu in neighbouring Philippines temporarily suspended travel to Sabah in response to the discovery of 'A701B' due to uncertainty over the nature of the mutation.[266]

On 25 December 2020, the Malaysian Ministry of Health described a mutation A701V as circulating and present in 85% of cases (D614G was present in 100% of cases) in Malaysia.[267] These reports also referred to samples collected from the Benteng Lahad Datu cluster. The text of the announcement was mirrored verbatim on the Facebook page of Noor Hisham Abdullah, Malay Director-General of Health, who was quoted in some of the news articles.

The A701V mutation has the amino acid alanine (A) substituted by valine (V) at position 701 in the spike protein. Globally, South Africa, Australia, Netherlands and England also reported A701V at about the same time as Malaysia. In GISAID, the prevalence of this mutation is found to be about 0.18%. of cases.[268]

On 14 April 2021, the Malaysian Ministry of Health reported that the third wave, which had started in Sabah, has involved the introduction of variants with D614G and A701V mutations.[269]

Recombinant variants

The British government has reported a number of recombinant variants of SARS-CoV-2.[270] These recombinant lineages have been given the Pango lineage identifiers XD, XE, and XF.[271]

XE is a recombinant lineage of Pango lineages BA.1 and BA.2.[272] XE was believed to have a growth rate 9.8% greater than BA.2.[270]

Differential vaccine effectiveness

The interplay between the SARS-CoV-2 virus and its human hosts was initially natural but then started being altered by the rising availability of vaccines seen in 2021.[273] The potential emergence of a SARS-CoV-2 variant that is moderately or fully resistant to the antibody response elicited by the COVID-19 vaccines may necessitate modification of the vaccines. The emergence of vaccine-resistant variants is more likely in a highly vaccinated population with uncontrolled transmission.[274]

As of February 2021, the US Food and Drug Administration believed that all FDA authorized vaccines remained effective in protecting against circulating strains of SARS-CoV-2.

Immune evasion by variants

Vaccine adjustments

Data and methods

Modern DNA sequencing, where available, may permit rapid detection (sometimes known as 'real-time detection') of genetic variants that appear in pathogens during disease outbreaks.[275] Through use of phylogenetic tree visualisation software, records of genome sequences can be clustered into groups of identical genomes all containing the same set of mutations. Each group represents a 'variant', 'clade', or 'lineage', and comparison of the sequences allows the evolutionary path of a virus to be deduced. For SARS-CoV-2, until March 2021, over 330,000 viral genomic sequences had been generated by molecular epidemiology studies across the world.[276]

New variant detection and assessment

On 26 January 2021, the British government said it would share its genomic sequencing capabilities with other countries in order to increase the genomic sequencing rate and trace new variants, and announced a "New Variant Assessment Platform".[277], more than half of all genomic sequencing of COVID-19 was carried out in the UK.[278]

Wastewater surveillance was demonstrated to be one technique to detect SARS-CoV-2 variants[204] and to track their rise for studying related ongoing infection dynamics.[279] [280] [281]

Testing

Whether one or more mutations visible in RT-PCR tests can be used reliably to identify a variant depends on the prevalence of other variants currently circulating in the same population.[282] [283]

Mutations used to identify variants of concern in commercial test assays[284]
MutationAlphaBetaGammaDeltaOmicron
Δ69–70
ins214EPE
S371L/S373P
N501Y
E484K
E484A
L452R
nsp6:Δ106–108

Incubation theory for multiple mutated variants

See also: Antigenic escape and Escape mutation. Researchers have suggested that multiple mutations can arise in the course of the persistent infection of an immunocompromised patient, particularly when the virus develops escape mutations under the selection pressure of antibody or convalescent plasma treatment,[285] [286] with the same deletions in surface antigens repeatedly recurring in different patients.[287]

Cross-species transmission

There is a risk that COVID-19 could transfer from humans to other animal populations and could combine with other animal viruses to create yet more variants that are dangerous to humans.[288] Reverse zoonosis spillovers may cause reservoirs for mutating variants that spill back to humans – another possible source for variants of concern, in addition to immunocompromised people.[289]

Cluster 5

See main article: Cluster 5. In early November 2020, Cluster 5, also referred to as ΔFVI-spike by the Danish State Serum Institute (SSI),[290] was discovered in Northern Jutland, Denmark. It is believed to have been spread from minks to humans via mink farms. On 4 November 2020, it was announced that the mink population in Denmark would be culled to prevent the possible spread of this mutation and reduce the risk of new mutations happening. A lockdown and travel restrictions were introduced in seven municipalities of Northern Jutland to prevent the mutation from spreading, which could compromise national or international responses to the COVID-19 pandemic. By 5 November 2020, some 214 mink-related human cases had been detected.[291]

The WHO stated that cluster 5 had a "moderately decreased sensitivity to neutralising antibodies".[292] SSI warned that the mutation could reduce the effect of COVID-19 vaccines under development, although it was unlikely to render them useless. Following the lockdown and mass-testing, SSI announced on 19 November 2020 that cluster 5 in all probability had become extinct.[293] As of 1 February 2021, authors to a peer-reviewed paper, all of whom were from the SSI, assessed that cluster 5 was not in circulation in the human population.[294]

See also

Further reading

External links

Notes and References

  1. Gary Kobinger. Shahhosseini N, Babuadze GG, Wong G, Kobinger GP . Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern . Microorganisms . 9 . 5 . 926 . April 2021 . 33925854 . 8146828 . 10.3390/microorganisms9050926 . 233460887 . free .
  2. News: 6 January 2021. Coronavirus variants and mutations: The science explained. en-GB. BBC News. 2 February 2021. 22 February 2021. https://web.archive.org/web/20210222193151/https://www.bbc.com/news/science-environment-55404988. live.
  3. Kupferschmidt K. 15 January 2021. New coronavirus variants could cause more reinfections, require updated vaccines. Science. 10.1126/science.abg6028. 234141081. 2 February 2021. 22 February 2021. https://web.archive.org/web/20210222193149/https://www.sciencemag.org/news/2021/01/new-coronavirus-variants-could-cause-more-reinfections-require-updated-vaccines. live.
  4. Web site: Origins of Coronaviruses . NIH.gov . 16 March 2022 . National Institutes of Health in the United States . 3 February 2023 . https://web.archive.org/web/20230121161451/https://www.niaid.nih.gov/diseases-conditions/origins-coronaviruses . 21 January 2023 . "To date, the origin of SARS-CoV-2 which caused the COVID-19 pandemic has not been identified.".
  5. Shahhosseini N, Wong G, Kobinger GP, Chinikar S . SARS-CoV-2 spillover transmission due to recombination event . Gene Reports . 23 . 101045 . June 2021 . 33615041 . 7884226 . 10.1016/j.genrep.2021.101045 .
  6. Web site: 2022-08-01 . The rise and fall of the lab leak hypothesis for the origin of SARS-CoV-2 Science-Based Medicine . 2022-11-04 . sciencebasedmedicine.org . en-US.
  7. Tang. Xiaolu. Wu. Changcheng. Li. Xiang. Song. Yuhe. 3 March 2020. On the origin and continuing evolution of SARS-CoV-2. National Science Review. 7. 6. 1012–1023. en. 10.1093/nsr/nwaa036. 34676127. 7107875. free.
  8. Forster. Peter. Forster. Lucy. Renfrew. Colin. Forster. Michael. 8 April 2020. Phylogenetic network analysis of SARS-CoV-2 genomes. Proceedings of the National Academy of Sciences. 117. 17. 9241–9243. en. 10.1073/pnas.2004999117. 0027-8424. 32269081. 7196762. 2020PNAS..117.9241F . free.
  9. Rambaut. A. Holmes. EC. OToole. A. Hill. V. McCrone. JT. Ruis. C. du Plessis. L. Pybus. OG. 15 July 2020. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nature Microbiology. 5. 11. 1403–1407. en. 10.1038/s41564-020-0770-5. 32669681. 7610519. free.
  10. Tregoning . John S. . Flight . Katie E. . Higham . Sophie L. . Wang . Ziyin . Pierce . Benjamin F. . Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape . Nature Reviews Immunology . 9 August 2021 . 21 . 10 . 626–636 . 10.1038/s41577-021-00592-1. 34373623 . 8351583 .
  11. Piplani . Sakshi . Singh . Puneet Kumar . Winkler . David A. . Petrovsky . Nikolai . In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin . Scientific Reports . December 2021 . 11 . 1 . 13063 . 10.1038/s41598-021-92388-5. 34168168 . 8225877 . 2021NatSR..1113063P .
  12. Web site: Gallagher J . 12 June 2021 . Covid: Is there a limit to how much worse variants can get? . . 12 June 2021 . 15 June 2021 . https://web.archive.org/web/20210615170043/https://www.bbc.co.uk/news/health-57431420 . live .
  13. Tao . Kaiming . Tzou . Philip L. . Nouhin . Janin . Gupta . Ravindra K. . de Oliveira . Tulio . Kosakovsky Pond . Sergei L. . Fera . Daniela . Shafer . Robert W. . The biological and clinical significance of emerging SARS-CoV-2 variants . Nature Reviews Genetics . 17 September 2021 . 22 . 12 . 757–773 . 10.1038/s41576-021-00408-x. 34535792 . 8447121 .
  14. Hendy . Mohamed . Kaufman . Samuel . Ponga . Mauricio . Molecular strategies for antibody binding and escape of SARS-CoV-2 and its mutations . Scientific Reports . December 2021 . 11 . 1 . 21735 . 10.1038/s41598-021-01081-0. 34741079 . 8571385 . 2021NatSR..1121735H .
  15. Web site: SARS-CoV-2 variants: risk assessment framework . GOV-8426 . GOV.UK . . Public Health England . 22 May 2021 . 22 June 2021 . 27 May 2021 . https://web.archive.org/web/20210527160412/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/988614/Risk_assessment_framework_for_SARS-CoV-2_variants_20210521.pdf . live .
  16. Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM, Planchais C, Porrot F, Robillard N, Puech J, Prot M . 27 May 2021 . Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals . 10.1101/2021.05.26.445838.
  17. Briefing . SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 10 . GOV-8226 . Public Health England . 7 May 2021 . PDF . 6 June 2021 . 8 May 2021 . https://web.archive.org/web/20210508185410/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/984274/Variants_of_Concern_VOC_Technical_Briefing_10_England.pdf . live .
  18. Callaway . Ewen . 2021-11-25 . Heavily mutated coronavirus variant puts scientists on alert . Nature . 600 . 7887 . 21 . 10.1038/d41586-021-03552-w. 34824381 . 244660616 . free . 2021Natur.600...21C .
  19. News: Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern . 26 November 2021 . World Health Organization . 26 November 2021.
  20. Briefing . SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 29 . GOV-10481 . Public Health England . 26 November 2021 . PDF . 26 November 2021 . 27 November 2021 . https://web.archive.org/web/20211127004349/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1036501/Technical_Briefing_29_published_26_November_2021.pdf . live .
  21. Web site: Rambaut A, Loman N, Pybus O, Barclay W, Barrett J, Carabelli A, Connor T, Peacock T, Robertson DL, Volz E . 18 December 2020 . Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations . 14 June 2021 . Virological . 21 December 2020 . https://web.archive.org/web/20201221015539/https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 . live .
  22. Briefing . Investigation of novel SARS-COV-2 variant, technical briefing 1 . Public Health England . 21 December 2020 . PDF . 6 June 2021 . 15 June 2021 . https://web.archive.org/web/20210615114312/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/959438/Technical_Briefing_VOC_SH_NJL2_SH2.pdf . live .
  23. Web site: 28 January 2021. Emerging SARS-CoV-2 Variants. 4 January 2021. CDC.gov. Centers for Disease Control and Prevention. Science brief. 15 May 2021. https://web.archive.org/web/20210515065224/https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html. live.
  24. News: Confirmed cases of COVID-19 variants identified in UK . Public Health England . GOV.UK . 15 January 2021 . 5 March 2021 . 7 May 2021 . https://web.archive.org/web/20210507162335/https://www.gov.uk/government/news/confirmed-cases-of-covid-19-variants-identified-in-uk . live .
  25. Horby P, Barclay W, Gupta R, Huntley C . Note . NERVTAG paper: note on variant P.1 . Public Health England . 27 January 2021 . 6 June 2021 . 6 June 2021 . https://web.archive.org/web/20210606142726/https://www.gov.uk/government/publications/nervtag-note-on-variant-p1-27-january-2021 . live .
  26. Note . NERVTAG paper: brief note on SARS-CoV-2 variants . Public Health England . 13 January 2021 . Horby P, Barclay W, Huntley C . 6 June 2021 . 6 June 2021 . https://web.archive.org/web/20210606142724/https://www.gov.uk/government/publications/nervtag-brief-note-on-sars-cov-2-variants-13-january-2021 . live .
  27. This table is an adaptation and expansion of .
  28. Web site: Nextclade. live. https://web.archive.org/web/20210119134022/https://clades.nextstrain.org/. 19 January 2021. 19 January 2021. nextstrain.org. What are the clades?.
  29. Web site: 29 June 2021 . SARS-CoV-2 Variant Classifications and Definitions . live . https://web.archive.org/web/20210616060332/https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveillance/variant-info.html . 16 June 2021 . 19 February 2021 . CDC.gov . Centers for Disease Control and Prevention. Frequently updated.
  30. Web site: Genomic epidemiology of novel coronavirus – Global subsampling (Filtered to B.1.617) . 5 May 2021 . nextstrain.org . 13 July 2021 . https://web.archive.org/web/20210713012054/https://nextstrain.org/ncov/gisaid/global?f_emerging_lineage=B.1.617 . live .
  31. Emergence of a Novel SARS-CoV-2 Variant in Southern California. 10.1001/jama.2021.1612. 0098-7484 . JAMA . 2021 . Zhang W, Davis B, Chen SS, Martinez JS, Plummer JT, Vail E . 325 . 13 . 1324–1326 . 33571356 . 7879386 . 2 October 2021.
  32. https://clades.nextstrain.org/ What are the clades?
  33. Web site: PANGO lineages-Lineage B.1.1.28 . cov-lineages.org . 4 February 2021 . 24 February 2021 . https://web.archive.org/web/20210224202809/https://cov-lineages.org/lineages/lineage_B.1.1.28.html . live .
  34. Web site: Variant: 20J/501Y.V3 . 1 April 2021 . 6 April 2021 . covariants.org . 23 March 2021 . https://web.archive.org/web/20210323204157/https://covariants.org/variants/S.501Y.V3 . live .
  35. Web site: Bedford T, Hodcroft B, Neher RA . Updated Nextstrain SARS-CoV-2 clade naming strategy . 6 January 2021 . nextstrain.org . 19 January 2021 . 18 January 2021 . https://web.archive.org/web/20210118211301/https://nextstrain.org/blog/2021-01-06-updated-SARS-CoV-2-clade-naming/ . live .
  36. Web site: 9 February 2021. Don't call it the 'British variant.' Use the correct name: B.1.1.7. 12 February 2021. STAT. en-US. 4 June 2021. https://web.archive.org/web/20210604173655/https://www.statnews.com/2021/02/09/not-british-variant-call-it-b117/. live.
  37. Web site: Flanagan R. 2 February 2021. Why the WHO won't call it the 'U.K. variant', and you shouldn't either. 12 February 2021. CTV News. en. 1 May 2021. https://web.archive.org/web/20210501143740/https://www.ctvnews.ca/health/coronavirus/why-the-who-won-t-call-it-the-u-k-variant-and-you-shouldn-t-either-1.5292441?cache=yes%3FclipId%3D1723871. live.
  38. For a list of sources using names referring to the country in which the variants were first identified, see, for example, and .
  39. Web site: Today, @WHO announces new, easy-to-say labels for #SARSCoV2 Variants of Concern (VOCs) & Interest (VOIs). en. 7 July 2021. 7 July 2021. https://web.archive.org/web/20210707021335/https://twitter.com/mvankerkhove/status/1399388129300205569. live.
  40. Web site: Branswell H . The name game for coronavirus variants just got a little easier . 31 May 2021 . Stat News . 28 June 2021 . 17 June 2021 . https://web.archive.org/web/20210617152927/https://www.statnews.com/2021/05/31/the-name-game-for-coronavirus-variants-just-got-a-little-easier/ . live .
  41. Web site: Statement on the sixth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic . 15 January 2021 . World Health Organization . 18 January 2021 . 7 February 2021 . https://web.archive.org/web/20210207131551/https://www.who.int/news/item/15-01-2021-statement-on-the-sixth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic . live .
  42. News: Covid: WHO renames UK and other variants with Greek letters. BBC News. 31 May 2021. en. 7 July 2021. 31 May 2021. https://web.archive.org/web/20210531234528/https://www.bbc.com/news/world-57308592. live.
  43. Web site: WHO skipped two Greek alphabet letters in naming coronavirus variant. 2021-11-27. The Associated Press.
  44. News: August 8, 2021. New COVID variants could be named after constellations once Greek alphabet is used up. Sky News. November 30, 2021.
  45. Koyama T, Platt D, Parida L . Variant analysis of SARS-CoV-2 genomes . Bulletin of the World Health Organization . 98 . 7 . 495–504 . July 2020 . 32742035 . 7375210 . 10.2471/BLT.20.253591 . We detected in total 65776 variants with 5775 distinct variants. . free .
  46. Alm E, Broberg EK, Connor T, Hodcroft EB, Komissarov AB, Maurer-Stroh S, Melidou A, Neher RA, O'Toole Á, Pereyaslov D . Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 . Euro Surveillance . 25 . 32 . August 2020 . 32794443 . 7427299 . 10.2807/1560-7917.ES.2020.25.32.2001410 . . The WHO European Region sequencing laboratories and GISAID EpiCoV group .
  47. Web site: Global phylogeny, updated by Nextstrain . GISAID . 19 January 2021 . 18 January 2021 . 20 January 2021 . https://web.archive.org/web/20210120112916/https://www.gisaid.org/phylodynamics/global/nextstrain/ . live .
  48. Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, Sagulenko P, Bedford T, Neher RA . Nextstrain: real-time tracking of pathogen evolution . Bioinformatics . 34 . 23 . 4121–4123 . December 2018 . 29790939 . 6247931 . 10.1093/bioinformatics/bty407 . Kelso J .
  49. Web site: Nextstrain COVID-19. 1 June 2021. Nextstrain. 21 January 2021. https://web.archive.org/web/20210121104048/https://nextstrain.org/ncov/global. live.
  50. Web site: cov-lineages/pangolin: Software package for assigning SARS-CoV-2 genome sequences to global lineages . Github . 2 January 2021 . 15 February 2021 . https://web.archive.org/web/20210215054819/https://github.com/cov-lineages/pangolin . live .
  51. Rambaut A, Holmes EC, O'Toole Á, Hill V, McCrone JT, Ruis C, du Plessis L, Pybus OG . A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology . Nature Microbiology . 5 . 11 . 1403–1407 . November 2020 . 32669681 . 7610519 . 10.1038/s41564-020-0770-5 . 220544096 . free . Cited in
  52. Rambaut A, Holmes EC, O'Toole Á, Hill V, McCrone JT, Ruis C, du Plessis L, Pybus OG . Addendum: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology . Nature Microbiology . 6 . 3 . 415 . March 2021 . 33514928 . 7845574 . 10.1038/s41564-021-00872-5 .
  53. Web site: Variants: distribution of cases data . GOV.UK . 28 January 2021 . At "Differences between a Variant of Concern and Variant Under Investigation" . 19 February 2021 . SARS-CoV-2 variants, if considered to have concerning epidemiological, immunological, or pathogenic properties, are raised for formal investigation. At this point they are designated Variant Under Investigation (VUI) with a year, month, and number. Following a risk assessment with the relevant expert committee, they may be designated Variant of Concern (VOC).
  54. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/961299/Variants_of_Concern_VOC_Technical_Briefing_6_England-1.pdf Investigation of SARS-CoV-2 variants of concern in EnglandTechnical briefing 6
  55. Web site: CDC. 2020-02-11. Cases, Data, and Surveillance. 2021-03-16. Centers for Disease Control and Prevention. en-us.
  56. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ . A new coronavirus associated with human respiratory disease in China . Nature . 579 . 7798 . 265–269 . March 2020 . 32015508 . 7094943 . 10.1038/s41586-020-2008-3 . 2020Natur.579..265W .
  57. Chiara M, Horner DS, Gissi C, Pesole G . Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2 . Molecular Biology and Evolution . 38 . 6 . 2547–2565 . May 2021 . 33605421 . 7928790 . 10.1093/molbev/msab049 .
  58. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL . A pneumonia outbreak associated with a new coronavirus of probable bat origin . Nature . 579 . 7798 . 270–273 . March 2020 . 32015507 . 7095418 . 10.1038/s41586-020-2012-7 . 2020Natur.579..270Z . Shi Zhengli .
  59. Okada P, Buathong R, Phuygun S, Thanadachakul T, Parnmen S, Wongboot W, Waicharoen S, Wacharapluesadee S, Uttayamakul S, Vachiraphan A, Chittaganpitch M, Mekha N, Janejai N, Iamsirithaworn S, Lee RT, Maurer-Stroh S . Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020 . Euro Surveillance . 25 . 8 . February 2020 . 32127124 . 7055038 . 10.2807/1560-7917.ES.2020.25.8.2000097 .
  60. Web site: Official hCoV-19 Reference Sequence . www.gisaid.org . 14 May 2021 . 6 May 2021 . https://web.archive.org/web/20210506170302/https://www.gisaid.org/epiflu-applications/hcov-19-reference-sequence/ . live .
  61. Kumar S, Tao Q, Weaver S, Sanderford M, Caraballo-Ortiz MA, Sharma S, Pond SL, Miura S . An evolutionary portrait of the progenitor SARS-CoV-2 and its dominant offshoots in COVID-19 pandemic . Molecular Biology and Evolution . May 2021 . 38 . 8 . 3046–3059 . 33942847 . 8135569 . 10.1093/molbev/msab118 .
  62. Web site: The ancestor of SARS-CoV-2's Wuhan strain was circulating in late October 2019. News Medical. 10 May 2020. Journal reference: Kumar, S. et al. (2021). An evolutionary portrait.... 24 July 2021. https://web.archive.org/web/20210724173715/https://www.news-medical.net/news/20210507/The-ancestor-of-SARS-CoV-2e28099s-Wuhan-strain-was-circulating-in-late-October-2019.aspx. live.
  63. Web site: Lineage descriptions . cov-lineages.org . Pango team . 24 December 2020 . 4 June 2021 . https://web.archive.org/web/20210604174159/https://cov-lineages.org/lineages.html . live .
  64. IDSA Contributor Web site: 2 February 2021. COVID "Mega-variant" and eight criteria for a template to assess all variants. 20 February 2021. Science Speaks: Global ID News. en-US. 21 April 2021. https://web.archive.org/web/20210421035437/https://sciencespeaksblog.org/2021/02/02/covid-mega-variant-and-eight-criteria-for-a-template-to-assess-all-variants/. live.
  65. CanCOGeN Interim Recommendations for Naming, Identifying, and Reporting SARS-CoV-2 Variants of Concern . 15 January 2021. 1.0 . CanCOGeN (nccid.ca) . Griffiths E, Tanner J, Knox N, Hsiao W, Van Domselaar G . 17 April 2021 . https://web.archive.org/web/20210417134703/https://nccid.ca/wp-content/uploads/sites/2/2021/02/CanCOGeN-Interim-Recommendations-for-Naming-Identifying-and-Reporting-SARS-CoV-2-Variants.pdf . live .
  66. Web site: Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. 2021-11-26. www.who.int. en.
  67. Callaway. Ewen. 2021-11-25. Heavily mutated coronavirus variant puts scientists on alert. Nature. 600. 7887. 21. en. 10.1038/d41586-021-03552-w. 34824381. 244660616. free. 2021Natur.600...21C .
  68. Web site: Fernando . Michael James and Christine . World experts hold special meeting on worrying new COVID-19 variant in South Africa: Latest updates . USA Today.
  69. Web site: outbreak.info. 2021-11-26. outbreak.info. en.
  70. https://www.bbc.co.uk/news/health-59418127 Covid: New heavily mutated variant B.1.1.529 in South Africa raises concern
  71. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ Tracking SARS-CoV-2 variants
  72. Web site: Whiteside. Philip. 30 November 2021. COVID-19: How the spread of Omicron went from patient zero to all around the globe. 2022-01-03. Sky News. en.
  73. BNODesk . 1464132888673280016 . Statement from Israel's health ministry reporting 1 confirmed case of new coronavirus variant B.1.1.529 . 26 November 2021. 26 November 2021.
  74. https://m.ynet.co.il/articles/syyt2za00y 14:30 4 מאומתים לווריאנט החדש התגלו בארץ, רה"מ יקיים מסיבת עיתונאים
  75. News: 2021-11-26. Belgium detects first case of new COVID-19 variant in Europe. en. Reuters. 2021-11-26.
  76. Web site: January 10, 2022. INSACOG WEEKLY BULLETIN. January 24, 2022. dbtindia.gov.in.
  77. Web site: Statement on Omicron sublineage BA.2 . 2022-04-04 . www.who.int . en.
  78. Web site: Schmidt . Charles . What We Know About Omicron's BA.2 Variant So Far . 2022-04-04 . Scientific American . en.
  79. News: . 11 March 2022 . Covid infections rising again across UK - ONS . BBC News .
  80. News: BA.2 is Now the Dominant COVID Variant in US, CDC Data Shows . Jessica Rendall . 29 March 2022 .
  81. Web site: ECDC . 2022-05-12 . Changes to list of SARS-CoV-2 variants of concern, variants of interest, and variants under monitoring .
  82. Web site: Omicron XBB.1.5: What Do We Know So Far? . Peter Russell . 6 January 2023 . 8 January 2023.
  83. Web site: SARS-CoV-2 genome sequence prevalence and growth rate update: 8 November 2023 . GOV.UK . 21 December 2023 . en . 6 December 2023.
  84. Web site: Johnson . Arianna . What We Know About 'Eris' Covid Variant EG.5: The Dominant Strain Driving An Uptick In Cases . 2023-08-11 . Forbes . en.
  85. Web site: cov-lineages.org . August 11, 2023.
  86. Web site: Smitha . Mundasad . What we know about the Covid variant EG.5 dubbed 'Eris' . BBC News . BBC . 10 August 2023 . 10 August 2023.
  87. Web site: COVID-19 Weekly Epidemiological Update (Edition 156 published 17 August 2023) . 17 August 2023 . World Health Organization . 30 August 2023 .
  88. Web site: Covid: Everything we know about the new Omicron descendant as winter flu surges . The Independent . 16 December 2023 . en . 8 December 2023.
  89. Bartel . Alexander . Grau . José Horacio . Bitzegeio . Julia . Werber . Dirk . Linzner . Nico . Schumacher . Vera . Garske . Sonja . Liere . Karsten . Hackenbeck . Thomas . Rupp . Sofia Isabell . Sagebiel . Daniel . Böckelmann . Uta . Meixner . Martin . 2024-01-10 . Timely Monitoring of SARS-CoV-2 RNA Fragments in Wastewater Shows the Emergence of JN.1 (BA.2.86.1.1, Clade 23I) in Berlin, Germany . Viruses . en . 16 . 1 . 102 . 10.3390/v16010102 . free . 38257802 . 10818819 . 1999-4915.
  90. News: 19 December 2023 . Initial Risk Evaluation of JN.1, 19 December 2023 . 11 January 2024 . World Health Organization.
  91. Web site: Return of the mask? Singapore, Indonesia bring back limits as Covid cases jump . mint . 16 December 2023 . en . 14 December 2023.
  92. News: 5 January 2024 . COVID-19 Activity Increases as Prevalence of JN.1 Variant Continues to Rise . 11 January 2024 . Centers for Disease Control and Prevention.
  93. live.
  94. News: New COVID 'FLiRT' variants are spreading nationwide. Chicago health experts urge up to date vaccination. Leventis Lourgos. Angie . Yahoo News. Chicago Tribune. May 9, 2024. May 14, 2024.
  95. Web site: Kee . Caroline . 2024-05-20 . The new COVID variants spreading in the US are called 'FLiRT.' But why? . 2024-05-29 . TODAY.com .
  96. live.
  97. Web site: Statement on the update of WHO's working definitions and tracking system for SARS-CoV-2 variants of concern and variants of interest . 2023-12-29 . www.who.int . en.
  98. Web site: Updated working definitions and primary actions for SARSCoV2 variants . 2023-12-29 . www.who.int . en.
  99. News: 20 December 2020 . Covid: Ireland, Italy, Belgium and Netherlands ban flights from UK . BBC News . live . 23 December 2020 . https://web.archive.org/web/20201221060553/https://www.bbc.co.uk/news/world-europe-55385768 . 21 December 2020.
  100. Investigation of novel SARS-COV-2 variant: Variant of Concern 202012/01 . 21 December 2020 . Public Health England . 23 December 2020 . https://web.archive.org/web/20210222193118/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/959438/Technical_Briefing_VOC_SH_NJL2_SH2.pdf . 22 February 2021 . live . Chand M, Hopkins S, Dabrera G, Achison C, Barclay W, Ferguson N, Volz E, Loman N, Rambaut A, Barrett J . .
  101. Web site: 14 December 2020 . PHE investigating a novel strain of COVID-19 . Public Health England (PHE).
  102. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations . Written on behalf of COVID-19 Genomics Consortium UK . 20 December 2020 . https://web.archive.org/web/20210222193119/https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 . 22 February 2021 . live . Rambaut A, Loman N, Pybus O, Barclay W, Barrett J, Carabelli A, Connor T, Peacock TL, Robertson D, Vol E . 2020.
  103. Web site: 20 December 2020 . Mutant coronavirus in the United Kingdom sets off alarms but its importance remains unclear . live . https://web.archive.org/web/20201221024340/https://www.sciencemag.org/news/2020/12/mutant-coronavirus-united-kingdom-sets-alarms-its-importance-remains-unclear . 21 December 2020 . 21 December 2020 . . en . Kupferschmidt K.
  104. Collier DA, De Marco A, Ferreira IA, Meng B, Datir RP, Walls AC, Kemp SA, Bassi J, Pinto D, Silacci-Fregni C, Bianchi S, Tortorici MA, Bowen J, Culap K, Jaconi S, Cameroni E, Snell G, Pizzuto MS, Pellanda AF, Garzoni C, Riva A, Elmer A, Kingston N, Graves B, McCoy LE, Smith KG, Bradley JR, Temperton N, Ceron-Gutierrez L, Barcenas-Morales G, Harvey W, Virgin HW, Lanzavecchia A, Piccoli L, Doffinger R, Wills M, Veesler D, Corti D, Gupta RK . May 2021 . Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies . Nature . Published . 593 . 7857 . 136–141 . 10.1038/s41586-021-03412-7 . 33706364 . We therefore generated pseudoviruses that carried the B.1.1.7 spike mutations with or without the additional E484K substitution and tested these against sera obtained after the first and second dose of the BNT162b2 mRNA vaccine as well as against convalescent sera. After the second vaccine dose, we observed a considerable loss of neutralising activity for the pseudovirus with the B.1.1.7 spike mutations and E484K (Fig. 3d, e). The mean fold change for the E484K-containing B.1.1.7 spike variant was 6.7 compared with 1.9 for the B.1.1.7 variant, relative to the wild-type spike protein (Fig. 3a–c and Extended Data Fig. 5). Similarly, when we tested a panel of convalescent sera with a range of neutralisation titres (Fig. 1f, g and Extended Data Fig. 5), we observed additional loss of activity against the mutant B.1.1.7 spike with E484K, with fold change of 11.4 relative to the wild-type spike protein (Fig. 3f, g and Extended Data Fig. 5). . free. 7899479 .
  105. Web site: 15 December 2020 . New evidence on VUI-202012/01 and review of the public health risk assessment . live . https://web.archive.org/web/20201221173146/https://khub.net/documents/135939561/338928724/New+SARS-COV-2+variant+-+information+and+risk+assessment.pdf/b56d4591-0466-1a18-28dc-010e0fdeef53 . 21 December 2020 . 25 December 2020 . Knowledge Hub.
  106. Web site: COG-UK Showcase Event . 18 December 2020 . live . https://web.archive.org/web/20210614074556/https://www.youtube.com/watch?v=G3CT9N89L-c&t=9399 . 14 June 2021 . 25 December 2020 . YouTube.
  107. Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, Pearson CA, Russell TW, Tully DC, Washburne AD, Wenseleers T, Gimma A, Waites W, Wong KL, van Zandvoort K, Silverman JD, Diaz-Ordaz K, Keogh R, Eggo RM, Funk S, Jit M, Atkins KE, Edmunds WJ . April 2021 . Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England . Science . 372 . 6538 . eabg3055 . 10.1126/science.abg3055 . 8128288 . 33658326.
  108. Volz E, Mishra S, Chand M, Barrett JC, Johnson R, Geidelberg L, Hinsley WR, Laydon DJ, Dabrera G, O'Toole Á, Amato R, Ragonnet-Cronin M, Harrison I, Jackson B, Ariani CV, Boyd O, Loman NJ, McCrone JT, Gonçalves S, Jorgensen D, Myers R, Hill V, Jackson DK, Gaythorpe K, Groves N, Sillitoe J, Kwiatkowski DP, Flaxman S, Ratmann O, Bhatt S, Hopkins S, Gandy A, Rambaut A, Ferguson NM . May 2021 . Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England . Nature . 593 . 7858 . 266–269 . 2021Natur.593..266V . 10.1038/s41586-021-03470-x . 33767447 . free. 10044/1/87474 . free .
  109. Web site: 11 February 2021 . NERVTAG paper on COVID-19 variant of concern B.1.1.7: NERVTAG update note on B.1.1.7 severity (2021-02-11) . live . https://web.archive.org/web/20210413135005/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/961042/S1095_NERVTAG_update_note_on_B.1.1.7_severity_20210211.pdf . 13 April 2021 . 26 February 2021 . GOV.UK . Horby P, Huntley C, Davies N, Edmunds J, Ferguson N, Medley G, Hayward A, Cevik M, Semple C.
  110. News: 22 January 2021 . Coronavirus: UK variant 'may be more deadly' . BBC News . live . 22 January 2021 . https://web.archive.org/web/20210523080035/https://www.bbc.com/news/health-55768627 . 23 May 2021 . Gallagher J.
  111. Frampton D, Rampling T, Cross A, Bailey H, Heaney J, Byott M, Scott R, Sconza R, Price J, Margaritis M, Bergstrom M, Spyer MJ, Miralhes PB, Grant P, Kirk S, Valerio C, Mangera Z, Prabhahar T, Moreno-Cuesta J, Arulkumaran N, Singer M, Shin GY, Sanchez E, Paraskevopoulou SM, Pillay D, McKendry RA, Mirfenderesky M, Houlihan CF, Nastouli E . April 2021 . Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study . The Lancet. Infectious Diseases . 21 . 9 . 1246–1256 . 10.1016/S1473-3099(21)00170-5 . 8041359 . 33857406.
  112. Web site: 15 May 2021 . PANGO lineages Lineage B.1.1.7 . live . https://web.archive.org/web/20210616191209/https://cov-lineages.org/lineages/lineage_B.1.1.7.html . 16 June 2021 . 15 May 2021 . cov-lineages.org.
  113. Web site: 2022-03-16 . Tracking SARS-CoV-2 variants (updated 2022-03-16) . live . https://web.archive.org/web/20220317033752/https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/. 2022-03-17 . 2022-03-17 . www.who.int . en.
  114. Web site: 2022-03-07 . Tracking SARS-CoV-2 variants (updated 2022-03-07) . live . https://web.archive.org/web/20220315215316/https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/. 2022-03-15 . 2022-05-21 . www.who.int . en.
  115. News: 5 March 2021 . In Oregon, Scientists Find a Virus Variant With a Worrying Mutation – In a single sample, geneticists discovered a version of the coronavirus first identified in Britain with a mutation originally reported in South Africa. . The New York Times . live . 6 March 2021 . https://web.archive.org/web/20210306000310/https://www.nytimes.com/2021/03/05/health/virus-oregon-variant.html . 6 March 2021 . Mandavilli A.
  116. Chen RE, Zhang X, Case JB, Winkler ES, Liu Y, VanBlargan LA, Liu J, Errico JM, Xie X, Suryadevara N, Gilchuk P, Zost SJ, Tahan S, Droit L, Turner JS, Kim W, Schmitz AJ, Thapa M, Wang D, Boon AC, Presti RM, O'Halloran JA, Kim AH, Deepak P, Pinto D, Fremont DH, Crowe JE, Corti D, Virgin HW, Ellebedy AH, Shi PY, Diamond MS . April 2021 . Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies . Nature Medicine . 27 . 4 . 717–726 . 10.1038/s41591-021-01294-w . 8058618 . 33664494 . free.
  117. Web site: 5 March 2021 . B.1.1.7 Lineage with S:E484K Report . live . https://web.archive.org/web/20210307000537/https://outbreak.info/situation-reports?country=United%20Kingdom&country=United%20States&division=California&pango=B.1.1.7&muts=S%3AE484K&selected=United%20States&selectedType=country . 7 March 2021 . 7 March 2021 . outbreak.info.
  118. 10.1101/2021.04.21.440801 . Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 isolates from Pennsylvania . 21 April 2021 . Moustafa AM, Bianco C, Denu L, Ahmed A, Neide B, Everett J, Reddy S, Rabut E, Deseignora J, Feldman MD, Rodino KG, Bushman F, Harris RM, Mell JC, Planet PJ .
  119. Web site: B.1.1.7 Lineage with S:E484K Report . live . https://web.archive.org/web/20210703045440/https://outbreak.info/situation-reports?pango=B.1.1.7&muts=S%3AE484K . 3 July 2021 . 28 May 2021 . outbreak.info.
  120. Risk assessment. Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update. European Centre for Disease Prevention and Control. 2 February 2021. 22 March 2021. 25 March 2021. https://web.archive.org/web/20210325174702/https://www.ecdc.europa.eu/en/publications-data/covid-19-risk-assessment-spread-new-variants-concern-eueea-first-update. live.
  121. Web site: 18 December 2020 . South Africa announces a new coronavirus variant . live . https://web.archive.org/web/20201221073359/https://www.nytimes.com/2020/12/19/world/south-africa-announces-a-new-coronavirus-variant.html . 21 December 2020 . 20 December 2020 . The New York Times.
  122. News: 18 December 2020 . South Africa coronavirus: Second wave fueled by new strain, teen 'rage festivals' . The Washington Post . live . 20 December 2020 . https://archive.today/20201227162427/https://www.washingtonpost.com/world/africa/south-africa-coronavirus-second-wave/2020/12/18/d4a51aec-3ff7-11eb-b58b-1623f6267960_story.html . 27 December 2020 . Wroughton L, Bearak M.
  123. Mkhize Z . 18 December 2020 . Update on Covid-19 (18th December 2020) . South Africa . COVID-19 South African Online Portal . 23 December 2020 . Our clinicians have also warned us that things have changed and that younger, previously healthy people are now becoming very sick. . 4 May 2021 . https://web.archive.org/web/20210504151326/https://sacoronavirus.co.za/2020/12/18/update-on-covid-19-18th-december-2020/ . live.
  124. Web site: Abdool Karim . Salim S. . 19 December 2020 . The 2nd Covid-19 wave in South Africa:Transmissibility & a 501.V2 variant, 11th slide . live . https://web.archive.org/web/20210106143155/https://www.scribd.com/document/488618010/Full-Presentation-by-SSAK-18-Dec . 6 January 2021 . 23 December 2020 . www.scribd.com.
  125. Web site: 22 December 2020 . The New Mutations . live . https://web.archive.org/web/20210129073128/https://blogs.sciencemag.org/pipeline/archives/2020/12/22/the-new-mutations . 29 January 2021 . 23 December 2020 . In the Pipeline . . I should note here that there's another strain in South Africa that is bringing on similar concerns. This one has eight mutations in the Spike protein, with three of them (K417N, E484K and N501Y) that may have some functional role. . Lowe D.
  126. Web site: 22 December 2020 . Statement of the WHO Working Group on COVID-19 Animal Models (WHO-COM) about the UK and South African SARS-CoV-2 new variants . live . https://web.archive.org/web/20210504151202/https://www.who.int/docs/default-source/blue-print/who-com-statement_new-variant_rev1.pdf . 4 May 2021 . 23 December 2020 . World Health Organization.
  127. . Novel mutation combination in spike receptor binding site . . 21 December 2020 . 23 December 2020 . 22 February 2021 . https://web.archive.org/web/20210222193121/https://www.gisaid.org/references/gisaid-in-the-news/novel-variant-combination-in-spike-receptor-binding-site/ . live.
  128. News: . 11 January 2021 . Japan finds new coronavirus variant in travelers from Brazil . . Japan . live . 14 January 2021 . https://web.archive.org/web/20210111105845/https://japantoday.com/category/national/corrected-update-3-japan-finds-new-coronavirus-variant-in-travellers-from-brazil . 11 January 2021.
  129. Web site: 12 January 2021 . Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings . live . https://web.archive.org/web/20210520082806/https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586 . 20 May 2021 . 23 January 2021 . virological.org . Faria NR, Claro IM, Candido D, Moyses Franco LA, Andrade PS, Coletti TM, Silva CA, Sales FC, Manuli ER, Aguiar RS, Gaburo . CADDE Genomic Network.
  130. Web site: 1 July 2021 . P.1 . live . https://web.archive.org/web/20210609174826/https://cov-lineages.org/global_report_P.1.html . 9 June 2021 . 7 March 2021 . cov-lineages.org . Pango team.
  131. Web site: Covid-19 Genomics UK Consortium . 15 January 2021 . COG-UK Report on SARS-CoV-2 Spike mutations of interest in the UK . live . https://web.archive.org/web/20210416040009/https://www.cogconsortium.uk/wp-content/uploads/2021/02/Report-2_COG-UK_SARS-CoV-2-Mutations.pdf . 16 April 2021 . 25 January 2021 . www.cogconsortium.uk.
  132. Voloch CM, da Silva Francisco R, de Almeida LG, Cardoso CC, Brustolini OJ, Gerber AL, Guimarães AP, Mariani D, da Costa RM, Ferreira OC, Frauches TS, de Mello CM, Leitão IC, Galliez RM, Faffe DS, Castiñeiras TM, Tanuri A, de Vasconcelos AT . March 2021 . Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil . Journal of Virology . 95 . 10 . 10.1128/jvi.00119-21 . 8139668 . 33649194 . free.
  133. Nascimento V, Souza V . 25 February 2021 . COVID-19 epidemic in the Brazilian state of Amazonas was driven by long-term persistence of endemic SARS-CoV-2 lineages and the recent emergence of the new Variant of Concern P.1 . live . 10.21203/rs.3.rs-275494/v1 . https://web.archive.org/web/20210301193848/https://www.researchsquare.com/article/rs-275494/v1 . 1 March 2021 . 2 March 2021 . free . Research Square.
  134. Faria NR, Mellan TA, Whittaker C, Claro IM, Candido DD, Mishra S, Crispim MA, Sales FC, Hawryluk I, McCrone JT, Hulswit RJ, Franco LA, Ramundo MS, de Jesus JG, Andrade PS, Coletti TM, Ferreira GM, Silva CA, Manuli ER, Pereira RH, Peixoto PS, Kraemer MU, Gaburo N, Camilo CD, Hoeltgebaum H, Souza WM, Rocha EC, de Souza LM, de Pinho MC, Araujo LJ, Malta FS, de Lima AB, Silva JD, Zauli DA, Ferreira AC, Schnekenberg RP, Laydon DJ, Walker PG, Schlüter HM, Dos Santos AL, Vidal MS, Del Caro VS, Filho RM, Dos Santos HM, Aguiar RS, Proença-Modena JL, Nelson B, Hay JA, Monod M, Miscouridou X, Coupland H, Sonabend R, Vollmer M, Gandy A, Prete CA, Nascimento VH, Suchard MA, Bowden TA, Pond SL, Wu CH, Ratmann O, Ferguson NM, Dye C, Loman NJ, Lemey P, Rambaut A, Fraiji NA, Carvalho MD, Pybus OG, Flaxman S, Bhatt S, Sabino EC . May 2021 . Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil . Science . 372 . 6544 . 815–821 . 2021Sci...372..815F . 10.1126/science.abh2644 . 0036-8075 . 8139423 . 33853970 . Within this plausible region of parameter space, P.1 can be between 1.7 and 2.4 times more transmissible (50% BCI, 2.0 median, with a 99% posterior probability of being >1) than local non-P1 lineages and can evade 21 to 46% (50% BCI, 32% median, with a 95% posterior probability of being able to evade at least 10%) of protective immunity elicited by previous infection with non-P.1 lineages, corresponding to 54 to 79% (50% BCI, 68% median) cross-immunity ... We estimate that infections are 1.2 to 1.9 times more likely (50% BCI, median 1.5, 90% posterior probability of being >1) to result in mortality in the period after the emergence of P.1, compared with before, although posterior estimates of this relative risk are also correlated with inferred cross-immunity. More broadly, the recent epidemic in Manaus has strained the city's health care system, leading to inadequate access to medical care. We therefore cannot determine whether the estimated increase in relative mortality risk is due to P.1 infection, stresses on the Manaus health care system, or both. Detailed clinical investigations of P.1 infections are needed. . free.
  135. News: 3 March 2021 . Brazil's Covid Crisis Is a Warning to the Whole World, Scientists Say – Brazil is seeing a record number of deaths, and the spread of a more contagious coronavirus variant that may cause reinfection. . The New York Times . live . 3 March 2021 . https://web.archive.org/web/20210303100523/https://www.nytimes.com/2021/03/03/world/americas/Brazil-covid-variant.html . 3 March 2021 . Andreoni M, Londoño E, Casado L.
  136. News: Carl Zimmer . 1 March 2021 . Virus Variant in Brazil Infected Many Who Had Already Recovered From Covid-19 – The first detailed studies of the so-called P.1 variant show how it devastated a Brazilian city. Now scientists want to know what it will do elsewhere. . The New York Times . live . 3 March 2021 . https://web.archive.org/web/20210303001526/https://www.nytimes.com/2021/03/01/health/covid-19-coronavirus-brazil-variant.html . 3 March 2021 . Zimmer C.
  137. Sofia Moutinho . 4 May 2021 . Chinese COVID-19 vaccine maintains protection in variant-plagued Brazil . live . Science . 10.1126/science.abi9414 . https://web.archive.org/web/20210616163500/https://www.sciencemag.org/news/2021/04/chinese-covid-19-vaccine-maintains-protection-variant-plagued-brazil . 16 June 2021 . 4 May 2021 . 234804602.
  138. News: 5 March 2021 . Exclusive: Oxford study indicates AstraZeneca effective against Brazil variant, source says . Reuters . Rio de Janeiro . live . 9 March 2021 . https://web.archive.org/web/20210309125137/https://www.reuters.com/article/us-health-coronavirus-brazil-variant-exc-idUSKBN2AX1NS . 9 March 2021 . Gaier R.
  139. News: 8 March 2021 . Exclusive: Oxford study indicates AstraZeneca effective against Brazil variant, source says . Reuters . Rio de Janeiro . live . 9 March 2021 . https://web.archive.org/web/20210309062645/https://www.reuters.com/article/us-health-coronavirus-brazil-variant-idINKBN2B026G . 9 March 2021.
  140. News: 8 March 2021 . CoronaVac e Oxford são eficazes contra variante de Manaus, dizem laboratórios . pt . CoronaVac and Oxford are effective against Manaus variant, say laboratories . UOL Notícias . Reuters Brazil . live . 9 March 2021 . https://web.archive.org/web/20210308235245/https://noticias.uol.com.br/ultimas-noticias/reuters/2021/03/08/exclusivo-coronavac-e-eficaz-contra-variante-de-manaus-mostram-dados-preliminares-de-estudo-do-butantan.htm . 8 March 2021 . Simões E, Gaier R.
  141. Web site: 22 September 2021 . Delta Globally Dominant Covid Strain, Now Spread To 185 Countries: WHO .
  142. Web site: PANGO lineages . live . https://web.archive.org/web/20210603085048/https://cov-lineages.org/lineages/lineage_B.1.617.html . 3 June 2021 . 18 April 2021 . cov-lineages.org.
  143. News: 8 April 2021 . Coronavirus Indian 'double mutant' strain named B.1.617 . en-IN . The Hindu . live . 10 April 2021 . https://web.archive.org/web/20210526012246/https://www.thehindu.com/news/national/indian-double-mutant-strain-named-b1617/article34274663.ece/amp/ . 26 May 2021 . Koshy J.
  144. News: 10 April 2021 . India's variant-fuelled second wave coincided with spike in infected flights landing in Canada . . live . 10 April 2021 . https://web.archive.org/web/20210602102218/https://torontosun.com/news/local-news/indias-variant-fuelled-second-wave-coincided-with-spike-in-infected-flights-landing-in-canada . 2 June 2021.
  145. Web site: 11 May 2021 . Weekly epidemiological update on COVID-19 . live . https://web.archive.org/web/20210511233906/https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---11-may-2021 . 11 May 2021 . 12 May 2021 . World Health Organization.
  146. Web site: COVID strain first detected in India found in 53 territories: WHO . live . https://web.archive.org/web/20210619135043/https://www.aljazeera.com/news/2021/5/26/covid-strain-first-detected-in-india-found-in-53-territories-who . 19 June 2021 . 27 May 2021 . www.aljazeera.com.
  147. Mishra . Swapnil . Mindermann . Sören . Sharma . Mrinank . Whittaker . Charles . Mellan . Thomas A. . Wilton . Thomas . Klapsa . Dimitra . Mate . Ryan . Fritzsche . Martin . Zambon . Maria . Ahuja . Janvi . 2021-09-01 . Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England . eClinicalMedicine . English . 39 . 101064 . 10.1016/j.eclinm.2021.101064 . 2589-5370 . 8349999 . 34401689.
  148. Web site: 7 May 2021 . British scientists warn over Indian coronavirus variant . live . https://web.archive.org/web/20210522193242/https://www.reuters.com/world/uk/british-officials-warn-over-indian-coronavirus-variant-reports-2021-05-07/ . 22 May 2021 . 7 May 2021 . Reuters.
  149. Web site: 7 May 2021 . expert reaction to VUI-21APR-02/B.1.617.2 being classified by PHE as a variant of concern . live . https://web.archive.org/web/20210713012051/https://www.sciencemediacentre.org/expert-reaction-to-vui-21apr-02-b-1-617-2-being-classified-by-phe-as-a-variant-of-concern/?cli_action=1621097773.028 . 13 July 2021 . 15 May 2021 . Science Media Centre.
  150. Briefing. SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 14. GOV-8530. Public Health England. 3 June 2021. PDF. 26 June 2021. 4 July 2021. https://web.archive.org/web/20210704205416/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/991343/Variants_of_Concern_VOC_Technical_Briefing_14.pdf. live.
  151. News: 11 June 2021 . AHS breaks down vaccination data of COVID-19 Delta variant outbreak at Calgary hospital . Global News . live . 12 June 2021 . https://web.archive.org/web/20210612051503/https://globalnews.ca/news/7943610/calgary-foothills-hospital-covid-19-delta-outbreak-vaccinations/ . 12 June 2021 . Pearson H, Pullen L, Dao C.
  152. News: 4 June 2021 . 'Nepal variant': What's the mutation stopping green list trips to Portugal? . BBC News . live . 18 June 2021 . https://web.archive.org/web/20210619162008/https://www.bbc.com/news/health-57356109 . 19 June 2021 . Schraer R.
  153. News: 23 June 2021 . Explainer: What is the Delta variant of coronavirus with K417N mutation? . Reuters . live . 23 June 2021 . https://web.archive.org/web/20210623101838/https://www.reuters.com/business/healthcare-pharmaceuticals/what-is-delta-variant-coronavirus-with-k417n-mutation-2021-06-23/ . 23 June 2021 . Acharya B, Jamkhandikar S.
  154. Briefing. SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 17. GOV-8576. Public Health England. 25 June 2021. PDF. 26 June 2021. 25 June 2021. https://web.archive.org/web/20210625212314/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/996740/Variants_of_Concern_VOC_Technical_Briefing_17.pdf. live.
  155. Web site: New 'Delta Plus' variant of SARS-CoV-2 identified; here's what we know so far . live . https://web.archive.org/web/20210617134931/https://www.indiatoday.in/coronavirus-outbreak/story/delta-plus-variant-covid-corona-coronavirus-sarscov2-1814768-2021-06-14 . 17 June 2021 . 16 June 2021 . India Today . en . Sharma M. 14 June 2021 .
  156. News: 18 June 2021 . 'Nepal variant': what we've learned so far . The Conversation . live . 18 June 2021 . https://web.archive.org/web/20210618153113/https://theconversation.com/nepal-variant-what-weve-learned-so-far-162227 . 18 June 2021 . Cutler S.
  157. Tang . Julian W. . Oliver . T.R. . 2021 . Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK . The Journal of Infection . 82 . 4 . e8–e10 . 10.1016/j.jinf.2021.01.007 . 7813514 . 33472093.
  158. News: 22 June 2021 . India says new COVID variant is a concern . Reuters . Bengaluru . live . 23 June 2021 . https://web.archive.org/web/20210623002010/https://www.reuters.com/world/india/india-reports-42640-new-covid-19-cases-1167-deaths-2021-06-22/ . 23 June 2021.
  159. News: 23 June 2021 . Delta plus: Scientists say too early to tell risk of Covid-19 variant . BBC News . live . 23 June 2021 . https://web.archive.org/web/20210623050608/https://www.bbc.com/news/world-asia-india-57564560 . 23 June 2021 . Biswas S.
  160. Web site: Roberts . Michelle . 19 October 2021 . Covid-19: New mutation of Delta variant under close watch in UK . 19 October 2021 . www.bbc.co.uk.
  161. Web site: 2022-06-07 . Tracking SARS-CoV-2 variants . live . https://web.archive.org/web/20220622021003/https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ . 2022-06-22 . 2022-06-23 . www.who.int . en.
  162. News: 11 February 2021 . Southern California COVID-19 Strain Rapidly Expands Global Reach . Cedars-Sinai Newsroom . . live . 17 March 2021 . https://web.archive.org/web/20210416012748/https://www.cedars-sinai.org/newsroom/southern-california-covid-19-strain-rapidly-expands-global-reach/ . 16 April 2021.
  163. Web site: B.1.429 Lineage Report . live . https://web.archive.org/web/20210703013524/https://outbreak.info/situation-reports?pango=B.1.429&loc=USA&loc=USA_US-CA&selected=USA_US-CA . 3 July 2021 . 28 May 2021 . outbreak.info . Latif AA, Mullen JL, Alkuzweny M, Tsueng G, Cano M, Haag E, Zhou J, Zeller M, Matteson N, Wu C, Andersen KG, Su AI, Gangavarapu K, Hughes LD . The Center for Viral Systems Biology.
  164. News: 19 January 2021 . New California Variant May Be Driving Virus Surge There, Study Suggests . . live . 20 January 2021 . https://web.archive.org/web/20210609201341/https://www.nytimes.com/2021/01/19/health/coronavirus-variant-california.html . 9 June 2021.
  165. News: 17 March 2021 . Coronavirus strains first detected in California are officially 'variants of concern,' CDC says . CNN . live . 6 June 2021 . https://web.archive.org/web/20210606142729/https://edition.cnn.com/2021/03/17/health/california-variants-of-concern-cdc/index.html . 6 June 2021 . Azad A.
  166. Shen X, Tang H, Pajon R, Smith G, Glenn GM, Shi W, Korber B, Montefiori DC . June 2021 . Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351 . The New England Journal of Medicine . 384 . 24 . 2352–2354 . 10.1056/NEJMc2103740 . 8063884 . 33826819 . free.
  167. Web site: 23 June 2021 . SARS-CoV-2 Variant Classifications and Definitions: Updated June 23, 2021 . dead . https://web.archive.org/web/20210629194456/https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html . 29 June 2021 . CDC.gov . Centers for Disease Control and Prevention.
  168. News: 14 May 2021 . How the United States Beat the Variants, for Now . . live . 17 May 2021 . https://web.archive.org/web/20210516211623/https://www.nytimes.com/2021/05/14/health/coronavirus-variants-united-states-of-america.html . 16 May 2021 . Zimmer C, Mandavilli A.
  169. News: 23 February 2021 . California coronavirus strain may be more infectious – and lethal . Science News . live . 17 March 2021 . https://web.archive.org/web/20210501092349/https://www.sciencemag.org/news/2021/02/coronavirus-strain-first-identified-california-may-be-more-infectious-and-cause-more . 1 May 2021 . 10.1126/science.abh2101 . Wadman M.
  170. News: 28 February 2021 . Do coronavirus tests work on variants? . San Francisco Chronicle . live . 24 June 2021 . https://web.archive.org/web/20210624212500/https://www.sfchronicle.com/health/article/Do-coronavirus-tests-work-on-variants-15980646.php . 24 June 2021 . Ho C.
  171. . Local COVID-19 Strain Found in Over One-Third of Los Angeles Patients . California . Cedars Sinai Medical Center . news wise . 19 January 2021 . 3 March 2021 . 13 June 2021 . https://web.archive.org/web/20210613110049/https://www.newswise.com/coronavirus/local-covid-19-strain-found-in-over-one-third-of-los-angeles-patients2 . live.
  172. Web site: 15 February 2021 . B.1.429 . live . https://web.archive.org/web/20210428155149/https://cov-lineages.org/lineages/lineage_B.1.429.html . 28 April 2021 . 16 February 2021 . Rambaut Group, University of Edinburgh . PANGO Lineages.
  173. Web site: 15 February 2021 . B.1.429 Lineage Report . live . https://web.archive.org/web/20210609094343/https://outbreak.info/situation-reports?country=United%20States%20of%20America&division=California&pango=B.1.429&selected=California&selectedType=division . 9 June 2021 . 16 February 2021 . . outbreak.info.
  174. Web site: COVID-19 Variant First Found in Other Countries and States Now Seen More Frequently in California . live . https://web.archive.org/web/20210616204152/https://www.cdph.ca.gov/Programs/OPA/Pages/NR21-020.aspx . 16 June 2021 . 30 January 2021 . California Department of Public Health.
  175. Web site: New strains of COVID swiftly moving through the US need careful watch, scientists say . live . https://web.archive.org/web/20210304154958/https://www.usatoday.com/story/news/health/2021/01/22/covid-new-virus-mutations-but-vaccines-fight-outbreak/4216815001/ . 4 March 2021 . 30 January 2021 . USA Today . en-US . Weise E, Weintraub K.
  176. Web site: 25 February 2021 . Delta-PCR-testen . The Delta PCR Test . live . https://web.archive.org/web/20210207104212/https://covid19.ssi.dk/diagnostik/delta-pcr-testen . 7 February 2021 . 27 February 2021 . Statens Serum Institut . Danish.
  177. Web site: GISAID hCOV19 Variants (see menu option 'G/484K.V3 (B.1.525)') . live . https://web.archive.org/web/20210623103745/https://www.gisaid.org/hcov19-variants/ . 23 June 2021 . 4 March 2021 . GISAID.
  178. Web site: 27 February 2021 . Status for udvikling af SARS-CoV-2 Variants of Concern (VOC) i Danmark . Status of development of SARS-CoV-2 Variants of Concern (VOC) in Denmark . live . https://web.archive.org/web/20210827180250/https://files.ssi.dk/covid19/virusvarianter/status/status-virusvarianter-27022021-l9k7 . 27 August 2021 . 27 February 2021 . Statens Serum Institut . Danish.
  179. Web site: 19 May 2021 . B.1.525 international lineage report . live . https://web.archive.org/web/20210609174829/https://cov-lineages.org/global_report_B.1.525.html . 9 June 2021 . 16 February 2021 . cov-lineages.org . Pango team.
  180. News: 16 February 2021 . Another new coronavirus variant seen in the UK . BBC News . live . 16 February 2021 . https://web.archive.org/web/20210620152732/https://www.bbc.com/news/health-56082573 . 20 June 2021 . Roberts M.
  181. Web site: 18 February 2021 . DOH confirms detection of 2 SARS-CoV-2 mutations in Region 7 . live . https://web.archive.org/web/20210503224212/https://news.abs-cbn.com/news/02/18/21/doh-to-investigate-2-mutations-of-concern-found-in-cebu . 3 May 2021 . 13 March 2021 . ABS-CBN News . en.
  182. News: 13 March 2021 . DOH reports COVID-19 variant 'unique' to PH, first case of Brazil variant . CNN Philippines . dead . 17 March 2021 . https://web.archive.org/web/20210316224353/https://cnnphilippines.com/news/2021/3/13/Philippines-new-COVID-19-variant-Brazil-UK-South-Africa.html . 16 March 2021 . Santos E.
  183. Web site: 13 March 2021 . DOH confirms new COVID-19 variant first detected in PH, first case of Brazil variant . live . https://web.archive.org/web/20210502100947/https://news.abs-cbn.com/news/03/13/21/doh-confirms-new-covid-19-variant-first-detected-in-ph-first-case-of-brazil-variant . 2 May 2021 . 13 March 2021 . ABS-CBN News . en.
  184. News: 13 March 2021 . PH discovered new COVID-19 variant earlier than Japan, expert clarifies . CNN Philippines . dead . 17 March 2021 . https://web.archive.org/web/20210317013626/https://www.cnnphilippines.com/news/2021/3/13/PH-COVID-19-variant-Japan.html . 17 March 2021.
  185. News: 13 March 2021 . Japan detects new coronavirus variant from traveler coming from PH . CNN Philippines . dead . 21 March 2021 . https://web.archive.org/web/20210316215007/https://cnnphilippines.com/news/2021/3/13/Japan-detects-new-coronavirus-variant-from-traveler-coming-from-PH.html . 16 March 2021.
  186. News: 17 March 2021 . UK reports 2 cases of COVID-19 variant first detected in Philippines . ABS-CBN . live . 21 March 2021 . https://web.archive.org/web/20210318044336/https://news.abs-cbn.com/overseas/03/17/21/uk-reports-2-cases-of-covid-19-variant-first-detected-in-philippines . 18 March 2021.
  187. Web site: 30 April 2021 . Covid-19: Sarawak detects variant reported in the Philippines . live . https://web.archive.org/web/20210501095348/https://www.thestar.com.my/news/nation/2021/04/30/covid-19-sarawak-detects-variant-reported-in-the-philippines . 1 May 2021 . 30 April 2021 . en.
  188. News: 24 February 2021 . A New Coronavirus Variant Is Spreading in New York, Researchers Report . The New York Times . live . 22 April 2021 . https://web.archive.org/web/20210426061820/https://www.nytimes.com/2021/02/24/health/coronavirus-variant-nyc.html . 26 April 2021 . Mandavilli A.
  189. Situation report. Weekly epidemiological update on COVID-19 – 27 April 2021. World Health Organization. 27 April 2021. 14 June 2021. 14 June 2021. https://web.archive.org/web/20210614035107/https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---27-april-2021/. live.
  190. News: 4 June 2021 . Indian covid-19 variant (B.1.617) . . live . 8 June 2021 . https://web.archive.org/web/20210623171254/https://www.newscientist.com/definition/indian-covid-19-variant-b-1-617/ . 23 June 2021 . Le Page M.
  191. News: 16 April 2021 . Arrival of India's 'double mutation' adds to variant woes, but threat posed remains unclear . en-GB . The Telegraph . live . 17 April 2021 . https://web.archive.org/web/20210621090618/https://www.telegraph.co.uk/global-health/science-and-disease/arrival-indias-double-mutation-adds-variant-woes-threat-posed/ . 21 June 2021 . 0307-1235 . Nuki P, Newey S.
  192. Web site: Covid 19 coronavirus: Ultra-contagious Lambda variant detected in Australia . live . https://web.archive.org/web/20210706114931/https://www.nzherald.co.nz/world/covid-19-coronavirus-ultra-contagious-lambda-variant-detected-in-australia/LAUYIDU2L7SSWMX6IQDTOYCX6A/ . 6 July 2021 . 6 July 2021 . NZ Herald. 6 July 2021 .
  193. Web site: COVID-19: Lambda variant may be more resistant to vaccines than other strains . live . https://web.archive.org/web/20210706073819/https://www.wionews.com/world/covid-19-lambda-variant-may-be-more-resistant-to-vaccines-than-other-strains-396116 . 6 July 2021 . 6 July 2021 . WION. 6 July 2021 .
  194. Web site: 6 July 2021 . Lambda variant: What is the new strain of Covid detected in the UK? . live . https://web.archive.org/web/20210706151620/https://www.independent.co.uk/news/health/covid-uk-lambda-variant-peru-b1878416.html . 6 July 2021 . 6 July 2021 . The Independent.
  195. News: 1 September 2021 . What is the Mu variant of COVID-19? . en-AU . www.abc.net.au . live . 1 September 2021 . https://web.archive.org/web/20210901052411/https://www.abc.net.au/news/2021-09-01/what-is-the-mu-variant-covid-delta-who/100424026 . 1 September 2021.
  196. Web site: O'Neill . Luke . Mu: everything you need to know about the new coronavirus variant of interest . live . https://web.archive.org/web/20210903222640/https://theconversation.com/mu-everything-you-need-to-know-about-the-new-coronavirus-variant-of-interest-167154 . 3 September 2021 . 2021-09-03 . The Conversation . 3 September 2021 . en.
  197. Web site: 23 December 2020. Detection of SARS-CoV-2 P681H Spike Protein Variant in Nigeria. 1 January 2021. Virological. en-US. 13 June 2021. https://web.archive.org/web/20210613184057/https://virological.org/t/detection-of-sars-cov-2-p681h-spike-protein-variant-in-nigeria/567. live.
  198. Web site: Lineage B.1.1.207. 11 March 2021. cov-lineages.org. Pango team. 27 January 2021. https://web.archive.org/web/20210127172920/https://cov-lineages.org/lineages/lineage_B.1.1.207.html. live.
  199. News: 3 March 2021. Queensland travellers have hotel quarantine extended after Russian variant of coronavirus detected. en-AU. www.abc.net.au. 3 March 2021. 3 March 2021. https://web.archive.org/web/20210303020815/https://www.abc.net.au/news/2021-03-03/coronavirus-queensland-russian-variant-quarantine-qantas-flight/13191524. live.
  200. News: New coronavirus variant found in West Bengal . www.thehindu.com . 21 April 2021 . 23 April 2021 . 26 May 2021 . https://web.archive.org/web/20210526091411/https://www.thehindu.com/sci-tech/health/new-coronavirus-variant-found-in-west-bengal/article34373083.ece . live . Koshy . Jacob .
  201. Web site: What is the new 'triple mutant variant' of Covid-19 virus found in Bengal? How bad is it? . www.indiatoday.in . 22 April 2021 . 23 April 2021 . 28 April 2021 . https://web.archive.org/web/20210428055736/https://www.indiatoday.in/amp/science/story/what-is-triple-mutant-variant-of-covid19-virus-bengal-strain-details-1793991-2021-04-22 . live .
  202. Web site: PANGO lineages Lineage B.1.618 . cov-lineages.org . 23 April 2021 . 14 May 2021 . https://web.archive.org/web/20210514093826/https://cov-lineages.org/lineages/lineage_B.1.618.html . live .
  203. News: Detecting novel SARS-CoV-2 variants in New York City wastewater . 10 March 2022 . . en.
  204. Smyth . Davida S. . Trujillo . Monica . Gregory . Devon A. . Cheung . Kristen . Gao . Anna . Graham . Maddie . Guan . Yue . Guldenpfennig . Caitlyn . Hoxie . Irene . Kannoly . Sherin . Kubota . Nanami . Lyddon . Terri D. . Markman . Michelle . Rushford . Clayton . San . Kaung Myat . Sompanya . Geena . Spagnolo . Fabrizio . Suarez . Reinier . Teixeiro . Emma . Daniels . Mark . Johnson . Marc C. . Dennehy . John J. . Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater . Nature Communications . 3 February 2022 . 13 . 1 . 635 . 10.1038/s41467-022-28246-3 . 35115523 . 8813986 . 2022NatCo..13..635S . en . 2041-1723.
  205. Web site: Browne. Ed. 2022-01-04. What we know about "IHU" COVID variant B.1.640.2 with 46 mutations. live. 2022-01-05. Newsweek. en. 5 January 2022. https://web.archive.org/web/20220105014846/https://www.newsweek.com/ihu-covid-variant-b-1-640-2-mutations-identified-france-1665299.
  206. Web site: Freund. Alexander. 2022-01-07. Coronavirus: Health experts not alarmed by variant identified in France. live. 2022-01-08. Deutsche Welle. en-GB. 7 January 2022. https://web.archive.org/web/20220107112455/https://www.dw.com/en/coronavirus-health-experts-not-alarmed-by-variant-identified-in-france/a-60329823.
  207. News: Bengali. Shashank. 2022-01-05. A variant found in France is not a concern, the W.H.O. says.. en-US. The New York Times. 2022-01-05. 0362-4331. 6 January 2022. https://web.archive.org/web/20220106020651/https://www.nytimes.com/2022/01/05/world/covid-variant-france.html. live.
  208. Web site: Tracking SARS-CoV-2 variants. live. 2022-01-05. World Health Organization. en. 25 November 2021. https://web.archive.org/web/20211125005036/https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/.
  209. Web site: Cobbe. Elaine. 2022-01-06. 'IHU' coronavirus variant 'on our radar' but not a threat, World Health Organization says. live. 2022-01-08. CBS News. en-US. 7 January 2022. https://web.archive.org/web/20220107020236/https://www.cbsnews.com/news/covid-ihu-variant-france-world-health-organization/.
  210. Web site: Freund. Alexander. 2022-01-04. New coronavirus variant identified in France. live. 2022-01-05. Deutsche Welle. en-GB. 5 January 2022. https://web.archive.org/web/20220105124646/https://www.dw.com/en/new-coronavirus-variant-identified-in-france/a-60329823.
  211. News: Chaturvedi. Amit. 4 January 2022. New Covid-19 variant 'IHU' discovered in France, has more mutations than Omicron. en. Hindustan Times. 5 January 2022. 5 January 2022. https://web.archive.org/web/20220105043808/https://www.hindustantimes.com/world-news/new-covid-19-variant-ihu-discovered-in-france-is-more-infectious-than-omicron-101641274969259.html. live.
  212. News: COVID-19: New variant, B.1.640.2, detected in France – study. The Jerusalem Post. 4 January 2022. 4 January 2022. https://web.archive.org/web/20220104051809/https://www.jpost.com/health-and-wellness/coronavirus/article-691458. live.
  213. News: What is the Deltacron variant of Covid and where has it been found? . 18 April 2022 . The Guardian . 11 March 2022 . en.
  214. News: Lapid . Nancy . Variant that combines Delta and Omicron identified; dogs sniff out virus with high accuracy . 18 April 2022 . Reuters . 9 March 2022 . en.
  215. Web site: COVID-19, Ukraine & Other Global Health Emergencies Virtual Press conference transcript - 16 March 2022 . www.who.int . 24 April 2022 . en.
  216. News: Snider . Mike . There may be a new COVID variant, Deltacron. Here's what we know about it. . 24 April 2022 . USA TODAY.
  217. Colson . Philippe . Fournier . Pierre-Edouard . Delerce . Jeremy . Million . Matthieu . Bedotto . Marielle . Houhamdi . Linda . Yahi . Nouara . Bayette . Jeremy . Levasseur . Anthony . Fantini . Jacques . Raoult . Didier . Scola . Bernard La . Culture and identification of a "Deltamicron" SARS-CoV-2 in a three cases cluster in southern France . 3739–3749 . en . 16 March 2022 . 10.1101/2022.03.03.22271812v2.
  218. Web site: Delta (AY.4) and BA.1 recombinant in France/Denmark [~30 seqs, isolated/passaged in Vero] · Issue #444 · cov-lineages/pango-designation ]. GitHub . 24 April 2022 . en.
  219. Web site: O'Neill . Luke . Deltacron: what scientists know so far about this new hybrid coronavirus . The Conversation . 21 March 2022 . 18 April 2022 . en.
  220. Web site: Scientists find 'most mutated' and 'most extreme' Covid variant ever in patient. Metro News. Sundaravelu. Anugraha. July 28, 2023. July 28, 2023.
  221. Web site: 新型コロナウイルス変異株とは | 日本医学臨床検査研究所 . What is the novel coronavirus mutation | Japan Medical Laboratory Laboratory . 3 September 2021 . 3 September 2021 . https://web.archive.org/web/20210903040942/https://www.jcl.co.jp/covheni. live.
  222. Web site: Variant: 21G (Lambda). CoVariants. 3 September 2021. 21 July 2021. https://web.archive.org/web/20210721095150/https://covariants.org/variants/21G.Lambda. live.
  223. Web site: More Data Point to Lambda Variant's Potential Lethality. Frank Diamond. Infection Control Today. 7 August 2021. 3 September 2021. 3 September 2021. https://web.archive.org/web/20210903142009/https://www.infectioncontroltoday.com/view/more-data-point-to-lambda-variant-s-potential-lethality. live.
  224. SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance . 2021 . 10.1016/j.celrep.2021.110218. 10.1101/2021.07.28.454085 . 3 September 2021 . 16 September 2021 . https://web.archive.org/web/20210916195937/https://www.biorxiv.org/content/10.1101/2021.07.28.454085v1 . live . Kimura . Izumi . Kosugi . Yusuke . Wu . Jiaqi . Yamasoba . Daichi . Butlertanaka . Erika P. . Tanaka . Yuri L. . Liu . Yafei . Shirakawa . Kotaro . Kazuma . Yasuhiro . Nomura . Ryosuke . Horisawa . Yoshihito . Tokunaga . Kenzo . Takaori-Kondo . Akifumi . Arase . Hisashi . Saito . Akatsuki . Nakagawa . So . Sato . Kei . 236520241 . Cell Reports. 38 . 2 . 110218 . 34968415 . 8683271 . 2433/267436 .
  225. Tandel D, Gupta D, Sah V, Harshan KH . 30 April 2021. N440K variant of SARS-CoV-2 has Higher Infectious Fitness. en. 10.1101/2021.04.30.441434.
  226. News: Bhattacharjee S . COVID-19 A.P. strain at least 15 times more virulent . The Hindu . 3 May 2021 . en-IN . 4 May 2021 . 10 May 2021 . https://web.archive.org/web/20210510130106/https://www.thehindu.com/news/national/andhra-pradesh/ap-strain-at-least-15-times-more-virulent/article34474035.ece . live .
  227. News: N440k Covid Variant: Mutant N440K 10 times more infectious than parent strain | Hyderabad News . The Times of India. 2 May 2021 . 3 September 2021. 30 August 2021. https://web.archive.org/web/20210830122055/https://timesofindia.indiatimes.com/city/hyderabad/mutant-n440k-10-times-more-infectious-than-parent-strain/articleshow/82348011.cms. live.
  228. Web site: 感染・伝播性の増加や抗原性の変化が懸念される 新型コロナウイルス(SARS-CoV-2)の新規変異株について (第13報) . New Mutant Strains of the Novel Coronavirus (SARS-CoV-2) Concerned About Increased Infectivity and Transmissibility and Changes in Antigenicity (13th Report) . 3 September 2021 . 3 September 2021 . https://web.archive.org/web/20210903035806/https://www.niid.go.jp/niid/ja/2019-ncov/2484-idsc/10623-covid19-57.html . live .
  229. Web site: Mutations in spike putatively linked to outbreak at Danish mink farms. GISAID. 3 September 2021. 3 September 2021. https://web.archive.org/web/20210903145541/https://www.gisaid.org/references/gisaid-in-the-news/mutations-in-spike-putatively-linked-to-outbreak-in-danish-mink-farms/. live.
  230. Web site: University of Graz. 22 February 2021. www.uni-graz.at. 6 May 2021. https://web.archive.org/web/20210506213944/https://www.uni-graz.at/en/university/. live.
  231. Web site: 23 January 2020. Coronavirus SARS-CoV-2 (formerly known as Wuhan coronavirus and 2019-nCoV) – what we can find out on a structural bioinformatics level. 22 February 2021. Innophore. en-US.
  232. Singh A, Steinkellner G, Köchl K, Gruber K, Gruber CC . Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2 . Scientific Reports . 11 . 1 . 4320 . February 2021 . 33619331 . 7900180 . 10.1038/s41598-021-83761-5 . free . 2021NatSR..11.4320S .
  233. Web site: BioNTech: We aspire to individualize cancer medicine. 22 February 2021. BioNTech. en. 18 June 2021. https://web.archive.org/web/20210618140029/https://biontech.de/. live.
  234. Schroers B, Gudimella R, Bukur T, Roesler T, Loewer M, Sahin U . 4 February 2021 . Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates . en . 10.1101/2021.02.04.429765.
  235. News: People Are Talking About A 'Double Mutant' Variant In India. What Does That Mean? . 27 April 2021 . ...scientifically, the term "double mutant" makes no sense, Andersen says. "SARS-CoV-2 mutates all the time. So there are many double mutants all over the place. The variant in India really shouldn't be called that." . NPR . en . 27 April 2021 . https://web.archive.org/web/20210427002806/https://www.npr.org/sections/goatsandsoda/2021/04/24/988744811/people-are-talking-about-a-double-mutant-variant-in-india-what-does-that-mean . live .
  236. Web site: Greenwood M . 15 January 2021 . What Mutations of SARS-CoV-2 are Causing Concern? . News Medical Lifesciences . 16 January 2021 . 16 January 2021 . https://web.archive.org/web/20210116155515/https://www.news-medical.net/health/What-Mutations-of-SARS-CoV-2-are-Causing-Concern.aspx . live .
  237. News: Mandavilli A, Mueller B . 2 March 2021 . Why Virus Variants Have Such Weird Names . The New York Times . 2 March 2021 . 0362-4331 . 20 June 2021 . https://web.archive.org/web/20210620205741/https://www.nytimes.com/2021/03/02/health/virus-variant-names.html . live .
  238. Web site: escape mutation . . 11 October 2012 . 19 February 2021 . 9 May 2021 . https://web.archive.org/web/20210509061951/https://i-base.info/escape-mutation/ . live .
  239. Wise J . Covid-19: The E484K mutation and the risks it poses . BMJ . 372 . n359 . February 2021 . 33547053 . 10.1136/bmj.n359 . 231821685 . free .
  240. . Brief report: New Variant Strain of SARS-CoV-2 Identified in Travelers from Brazil. Japan. NIID (National Institute of Infectious Diseases). 12 January 2021. 14 January 2021. 15 January 2021. https://web.archive.org/web/20210115073539/https://www.niid.go.jp/niid/images/epi/corona/covid19-33-en-210112.pdf. live.
  241. Briefing . Investigation of novel SARS-CoV-2 variant 202012/01, technical briefing 5 . GW-1905 . Public Health England . 2 February 2021 . PDF . 14 June 2021 . 29 June 2021 . https://web.archive.org/web/20210629153356/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/959426/Variant_of_Concern_VOC_202012_01_Technical_Briefing_5.pdf . live .
  242. Greaney AJ, Loes AN, Crawford KH, Starr TN, Malone KD, Chu HY, Bloom JD . Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies . Cell Host & Microbe . 29 . 3 . 463–476.e6 . March 2021 . 33592168 . 7869748 . 10.1016/j.chom.2021.02.003 .
  243. Kupferschmidt K . New mutations raise specter of 'immune escape' . Science . 371 . 6527 . 329–330 . January 2021 . 33479129 . 10.1126/science.371.6527.329 . free . 2021Sci...371..329K .
  244. News: Rettner R . UK coronavirus variant develops vaccine-evading mutation – In a handful of instances, the U.K. coronavirus variant has developed a mutation called E484K, which may impact vaccine effectiveness. . 2 February 2021 . . 2 February 2021 . 2 February 2021 . https://web.archive.org/web/20210202203636/https://www.livescience.com/uk-coronavirus-variant-mutation-e484k.html . live .
  245. News: Achenbach J, Booth W . Worrisome coronavirus mutation seen in U.K. variant and in some U.S. samples . 2 February 2021 . The Washington Post . 2 February 2021 . 2 February 2021 . https://web.archive.org/web/20210202233457/https://www.washingtonpost.com/health/new-covid-mutation-uk-variant/2021/02/02/a164f17a-6577-11eb-886d-5264d4ceb46d_story.html . live .
  246. Web site: 東京五輪で"最凶"の「ラムダ株」が上陸 ワクチン効果は5分の1? . "Lambda strain" landed at the Tokyo Olympics, and the vaccine effect is one-fifth? . gooニュース. 3 September 2021. 3 September 2021. https://web.archive.org/web/20210903142009/https://news.goo.ne.jp/article/dot/nation/dot-2021070600072.html. live.
  247. Web site: The Lambda variant: is it more infectious, and can it escape vaccines? A virologist explains. The Conversation. 21 July 2021 . 3 September 2021. 3 September 2021. https://web.archive.org/web/20210903163715/https://theconversation.com/the-lambda-variant-is-it-more-infectious-and-can-it-escape-vaccines-a-virologist-explains-164156. live.
  248. COG-UK update on SARS-CoV-2 Spike mutations of special interest: Report 1 . 20 December 2020 . COVID-19 Genomics UK Consortium (COG-UK) . 7 . 31 December 2020 . 25 December 2020 . https://web.archive.org/web/20201225050316/https://www.cogconsortium.uk/wp-content/uploads/2020/12/Report-1_COG-UK_20-December-2020_SARS-CoV-2-Mutations_final_updated2.pdf . dead .
  249. Web site: Researchers Discover New Variant of COVID-19 Virus in Columbus, Ohio . 13 January 2021 . wexnermedical.osu.edu . 16 January 2021 . 15 January 2021 . https://web.archive.org/web/20210115204337/https://wexnermedical.osu.edu/mediaroom/pressreleaselisting/new-sars-cov2-variant . live .
  250. Tu H, Avenarius MR, Kubatko L, Hunt M, Pan X, Ru P, Garee J, Thomas K, Mohler P, Pancholi P, Jones D . Distinct Patterns of Emergence of SARS-CoV-2 Spike Variants including N501Y in Clinical Samples in Columbus Ohio . 26 January 2021 . 10.1101/2021.01.12.426407 . en.
  251. Web site: 新たな変異ある「デルタ株」検出 感染力への影響分からず . Detection of a new mutant "Delta strain" The effect on infectivity is unknown . NHKニュース. 31 August 2021 . 2 September 2021. 1 September 2021. https://web.archive.org/web/20210901171436/https://www3.nhk.or.jp/news/html/20210831/k10013233451000.html. live.
  252. Web site: 「N501S 変異を有する新たなデルタ株(B.1.617.2 系統)の市中感染事例(国内第1例目)を確認」 〜医科歯科大 新型コロナウイルス全ゲノム解析プロジェクト 第8報〜 . "Confirmed a case of community-acquired infection (first case in Japan) of a new delta strain (B.1.617.2 strain) with N501S mutation" -Medical and Dental University New Coronavirus Whole Genome Analysis Project 8th Report- . 2 September 2021. 30 August 2021. https://web.archive.org/web/20210830063820/https://www.tmd.ac.jp/files/topics/55788_ext_04_2.pdf. live.
  253. News: Corum . Jonathan . Zimmer . Carl . Coronavirus Variant Tracker . 1 December 2021 . . 9 February 2021 . https://web.archive.org/web/20211130040553/https://www.nytimes.com/interactive/2021/health/coronavirus-variant-tracker.html . November 30, 2021 . live . Constantly Updated.
  254. News: Schraer R . Coronavirus: Are mutations making it more infectious? . BBC News . 18 July 2020 . 3 January 2021 . 30 December 2020 . https://web.archive.org/web/20201230185809/https://www.bbc.co.uk/news/health-53325771 . live .
  255. News: New, more infectious strain of COVID-19 now dominates global cases of virus: study . 16 August 2020 . medicalxpress.com . en . 17 November 2020 . https://web.archive.org/web/20201117010819/https://medicalxpress.com/news/2020-07-infectious-strain-covid-dominates-global.html . live .
  256. Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B, Hastie KM, Parker MD, Partridge DG, Evans CM, Freeman TM, de Silva TI, McDanal C, Perez LG, Tang H, Moon-Walker A, Whelan SP, LaBranche CC, Saphire EO, Montefiori DC . Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus . Cell . 182 . 4 . 812–827.e19 . August 2020 . 32697968 . 7332439 . 10.1016/j.cell.2020.06.043 . free .
  257. Hou YJ, Chiba S, Halfmann P, Ehre C, Kuroda M, Dinnon KH, Leist SR, Schäfer A, Nakajima N, Takahashi K, Lee RE, Mascenik TM, Graham R, Edwards CE, Tse LV, Okuda K, Markmann AJ, Bartelt L, de Silva A, Margolis DM, Boucher RC, Randell SH, Suzuki T, Gralinski LE, Kawaoka Y, Baric RS . SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo . Science . 370 . 6523 . 1464–1468 . December 2020 . 33184236 . 7775736 . 10.1126/science.abe8499 . an emergent Asp614→Gly (D614G) substitution in the spike glycoprotein of SARS-CoV-2 strains that is now the most prevalent form globally . 2020Sci...370.1464H .
  258. Volz EM, Hill V, McCrone JT, Price A, Jorgensen D, O'Toole A, Southgate J, Johnson R, Jackson B, Nascimento FB, Rey SM . 4 August 2020. Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity . Cell . 184 . 1 . 64–75.e11 . en. 10.1016/j.cell.2020.11.020. 33275900 . 7674007 . 10044/1/84079. free.
  259. Butowt R, Bilinska K, Von Bartheld CS . Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor . ACS Chemical Neuroscience . 11 . 20 . 3180–3184 . October 2020 . 32997488 . 7581292 . 10.1021/acschemneuro.0c00596 . free .
  260. Zhukova A, Blassel L, Lemoine F, Morel M, Voznica J, Gascuel O . Origin, evolution and global spread of SARS-CoV-2 . Comptes Rendus Biologies . 344 . 57–75 . November 2020 . 33274614 . 10.5802/crbiol.29 . free .
  261. Hodcroft . Emma B. . Domman . Daryl B. . Snyder . Daniel J. . Oguntuyo . Kasopefoluwa Y. . Van Diest . Maarten . Densmore . Kenneth H. . Schwalm . Kurt C. . Femling . Jon . Carroll . Jennifer L. . Scott . Rona S. . Whyte . Martha M. . Edwards . Michael W. . Hull . Noah C. . Kevil . Christopher G. . Vanchiere . John A. . Lee . Benhur . Dinwiddie . Darrell L. . Cooper . Vaughn S. . Kamil . Jeremy P. . Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677 . 21 February 2021 . 10.1101/2021.02.12.21251658.
  262. Web site: Study finds 7 newly-identified COVID-19 variants circulating in the United States. 15 February 2021. ABC11 Raleigh-Durham. 3 September 2021. 3 September 2021. https://web.archive.org/web/20210903124612/https://abc11.com/10342025/. live.
  263. Maison DP, Ching LL, Shikuma CM, Nerurkar VR . Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H Mutation . January 2021 . 10.1101/2021.01.06.425497 . Available under CC BY 4.0 .
  264. News: Study shows P681H mutation is becoming globally prevalent among SARS-CoV-2 sequences . 11 February 2021 . News-Medical.net . 10 January 2021 . en . 14 February 2021 . https://web.archive.org/web/20210214132128/https://www.news-medical.net/news/20210110/Study-shows-P681H-mutation-is-becoming-globally-prevalent-among-SARS-CoV-2-sequences.aspx . live .
  265. News: Malaysia identifies new Covid-19 strain, similar to one found in 3 other countries . Tan Sri Dr Noor Hisham Abdullah, said it is still unknown whether the strain – dubbed the "A701B" mutation – is more infectious than usual . 10 January 2021 . The Straits Times . 23 December 2020 . en . 23 December 2020 . https://web.archive.org/web/20201223152941/https://www.straitstimes.com/asia/se-asia/malaysia-has-identified-new-covid-19-strain-similar-to-one-found-in-3-other-nations . live .
  266. News: Duterte says Sulu seeking help after new COVID-19 variant detected in nearby Sabah, Malaysia . 10 January 2021 . GMA News . 27 December 2020 . en . 3 January 2021 . https://web.archive.org/web/20210103070045/https://www.gmanetwork.com/news/news/nation/769466/duterte-says-sulu-seeking-help-after-new-covid-19-strain-detected-in-nearby-sabah-malaysia/story/ . live .
  267. Web site: COVID-19 A701V mutation spreads to third wave clusters . 25 December 2020 . focusmalaysia.my . 13 May 2021 . 14 May 2021 . https://web.archive.org/web/20210514041003/https://focusmalaysia.my/mainstream/covid-19-a701v-mutation-spreads-to-third-wave-clusters/ . live .
  268. News: The current situation and Information on the Spike protein mutation of Covid-19 in Malaysia . 25 December 2020 . Kementerian Kesihatan Malaysia – Covid-19 Malaysia . 15 January 2021 . 2 July 2021 . https://web.archive.org/web/20210702224231/https://covid-19.moh.gov.my/semasa-kkm/122020/current-situation-and-information-on-the-spike-protein-mutation-of-covid-19-in-malaysia . live .
  269. Web site: Variants of Concerns (VOC), B.1.524, B.1.525, South African B.1.351, STRAIN D614G, A701V, B1.1.7 . 14 April 2021 . covid-19.moh.gov.my . 15 May 2021 . 2 July 2021 . https://web.archive.org/web/20210702203225/https://covid-19.moh.gov.my/semasa-kkm/2021/04/perkembangan-mutasi-covid-19-di-malaysia-14042021 . live .
  270. Web site: 25 March 2022 . SARS-CoV-2 variants of concern and variants under investigation in England : Technical briefing 39 . live . https://web.archive.org/web/20220404075240/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1063424/Tech-Briefing-39-25March2022_FINAL.pdf . 2022-04-04 . 2022-04-06 . gov.uk . UK Health Security Agency.
  271. Web site: 2 March 2022 . COVID-19 Weekly Epidemiological Update : Edition 84, published 22 March 2022 . 2022-04-06 . who.int . World Health Organization.
  272. Web site: Cov-Lineages . 2022-04-06 . cov-lineages.org.
  273. Burioni R, Topol EJ . June 2021 . Has SARS-CoV-2 reached peak fitness? . Nature Medicine . 27 . 8 . 1323–24 . 10.1038/s41591-021-01421-7 . 34155413 . free.
  274. Rella . Simon A. . Kulikova . Yuliya A. . Dermitzakis . Emmanouil T. . Kondrashov . Fyodor A. . 30 July 2021 . Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains . Scientific Reports . 11 . 1 . 15729 . 10.1038/s41598-021-95025-3 . 2045-2322 . 8324827 . 34330988.
  275. Yurkovetskiy L, Wang X, Pascal KE, Tomkins-Tinch C, Nyalile TP, Wang Y, Baum A, Diehl WE, Dauphin A, Carbone C, Veinotte K, Egri SB, Schaffner SF, Lemieux JE, Munro JB, Rafique A, Barve A, Sabeti PC, Kyratsous CA, Dudkina NV, Shen K, Luban J . Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant . Cell . 183 . 3 . 739–751.e8 . October 2020 . 32991842 . 7492024 . 10.1016/j.cell.2020.09.032 .
  276. Thomson EC, Rosen LE, Shepherd JG, Spreafico R, da Silva Filipe A, Wojcechowskyj JA, Davis C, Piccoli L, Pascall DJ, Dillen J, Lytras S, Czudnochowski N, Shah R, Meury M, Jesudason N, De Marco A, Li K, Bassi J, O'Toole A, Pinto D, Colquhoun RM, Culap K, Jackson B, Zatta F, Rambaut A, Jaconi S, Sreenu VB, Nix J, Zhang I, Jarrett RF, Glass WG, Beltramello M, Nomikou K, Pizzuto M, Tong L, Cameroni E, Croll TI, Johnson N, Di Iulio J, Wickenhagen A, Ceschi A, Harbison AM, Mair D, Ferrari P, Smollett K, Sallusto F, Carmichael S, Garzoni C, Nichols J, Galli M, Hughes J, Riva A, Ho A, Schiuma M, Semple MG, Openshaw PJ, Fadda E, Baillie JK, Chodera JD, Rihn SJ, Lycett SJ, Virgin HW, Telenti A, Corti D, Robertson DL, Snell G . Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity . Cell . 184 . 5 . 1171–1187.e20 . March 2021 . 33621484 . 7843029 . 10.1016/j.cell.2021.01.037 .
  277. Web site: 26 January 2021 . Britain to help other countries track down coronavirus variants . Smout A . Reuters . 27 January 2021 . 26 January 2021 . https://web.archive.org/web/20210126084735/https://www.reuters.com/article/us-health-coronavirus-britain-genome-idUSKBN29V00B . live .
  278. News: 26 January 2021 . UK to help sequence mutations of Covid around world to find dangerous new variants . Donnelly L . The Telegraph . 28 January 2021 . 27 January 2021 . https://web.archive.org/web/20210127230601/https://www.telegraph.co.uk/news/2021/01/26/uk-help-sequence-mutations-covid-around-world-find-dangerous/ . live .
  279. Galani . Aikaterini . Aalizadeh . Reza . Kostakis . Marios . Markou . Athina . Alygizakis . Nikiforos . Lytras . Theodore . Adamopoulos . Panagiotis G. . Peccia . Jordan . Thompson . David C. . Kontou . Aikaterini . Karagiannidis . Apostolos . Lianidou . Evi S. . Avgeris . Margaritis . Paraskevis . Dimitrios . Tsiodras . Sotirios . Scorilas . Andreas . Vasiliou . Vasilis . Dimopoulos . Meletios-Athanasios . Thomaidis . Nikolaos S. . SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions . Science of the Total Environment . January 2022 . 804 . 150151 . 10.1016/j.scitotenv.2021.150151. 34623953 . 8421077 . 2022ScTEn.80450151G .
  280. Baaijens . Jasmijn A. . Zulli . Alessandro . Ott . Isabel M. . Petrone . Mary E. . Alpert . Tara . Fauver . Joseph R. . Kalinich . Chaney C. . Vogels . Chantal B. F. . Breban . Mallery I. . Duvallet . Claire . McElroy . Kyle . Ghaeli . Newsha . Imakaev . Maxim . Mckenzie-Bennett . Malaika . Robison . Keith . Plocik . Alex . Schilling . Rebecca . Pierson . Martha . Littlefield . Rebecca . Spencer . Michelle . Simen . Birgitte B. . Hanage . William P. . Grubaugh . Nathan D. . Peccia . Jordan . Baym . Michael . Variant abundance estimation for SARS-CoV-2 in wastewater using RNA-Seq quantification . 2 September 2021 . 10.1101/2021.08.31.21262938.
  281. Heijnen . Leo . Elsinga . Goffe . Graaf . Miranda de . Molenkamp . Richard . Koopmans . Marion P. G. . Medema . Gertjan . Droplet Digital RT-PCR to detect SARS-CoV-2 variants of concern in wastewater . en . 26 March 2021 . 10.1101/2021.03.25.21254324v1.
  282. European Centre for Disease Prevention and Control, World Health Organization . Methods for the detection and identification of SARS-CoV-2 variants . European Centre for Disease Prevention and Control . 3 March 2021 . Stockholm . Diagnostic screening assays of known VOCs.
  283. Briefing . SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 15 . GOV-8576 . Public Health England . 11 June 2021 . PDF . 15 June 2021 . 4 July 2021 . https://web.archive.org/web/20210704221717/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/993879/Variants_of_Concern_VOC_Technical_Briefing_15.pdf . live .
  284. Assessment of the further emergence and potential impact of the SARS-CoV-2 Omicron variant of concern in the context of ongoing transmission of the Delta variant of concern in the EU/EEA, 18th update . European Centre for Disease Prevention and Control . 15 December 2021 . Stockholm . Annexes 1 and 2.
  285. U.K. variant puts spotlight on immunocompromised patients' role in the COVID-19 pandemic. Kupferschmidt K. 23 December 2020. Science. 10.1126/science.abg2911. 234378594. 25 February 2021. 24 June 2021. https://web.archive.org/web/20210624003243/https://www.sciencemag.org/news/2020/12/uk-variant-puts-spotlight-immunocompromised-patients-role-covid-19-pandemic. live.
  286. News: COVID Variants May Arise in People with Compromised Immune Systems. Sutherland S. 23 February 2021. Scientific American. 25 February 2021. 6 June 2021. https://web.archive.org/web/20210606220535/https://www.scientificamerican.com/article/covid-variants-may-arise-in-people-with-compromised-immune-systems/. live.
  287. McCarthy KR, Rennick LJ, Nambulli S, Robinson-McCarthy LR, Bain WG, Haidar G, Duprex WP . Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape . Science . 371 . 6534 . 1139–1142 . March 2021 . 33536258 . 7971772 . 10.1126/science.abf6950 . free . 2021Sci...371.1139M .
  288. Green ST, Cladi L . BMJ . Covid-19 and evolutionary pressure – can we predict which genetic dangers lurk beyond the horizon? . 26 January 2021 . n230 . 8 June 2021 . 8 June 2021 . https://web.archive.org/web/20210608083850/https://www.bmj.com/content/372/bmj.n230/rr . live .
  289. News: Jacobs . Andrew . Widespread Coronavirus Infection Found in Iowa Deer, New Study Says . https://ghostarchive.org/archive/20211228/https://www.nytimes.com/2021/11/02/science/deer-covid-infection.html . 2021-12-28 . limited . 12 December 2021 . The New York Times . 2 November 2021 . Researchers and outside experts characterized the study's findings as a troubling development in the course of the pandemic. Widespread infection among North America's most ubiquitous game species could make eradicating the pathogen even more difficult, especially if they became a reservoir for mutations that eventually spilled back over to humans. [...] they are alerting deer hunters and others who handle deer to take precautions to avoid transmission. [...] If the virus were to become endemic in wild animals like deer, it could evolve over time to become more virulent and then infect people with a new strain capable of evading the current crop of vaccines..
  290. Preprint. Lassaunière R, Fonager J, Rasmussen M, Frische A, Strandh C, Rasmussen T, Bøtner A, Fomsgaard A. 10 November 2020. SARS-CoV-2 spike mutations arising in Danish mink, their spread to humans and neutralization data. Statens Serum Institut. live. https://web.archive.org/web/20201110135434/https://files.ssi.dk/Mink-cluster-5-short-report_AFO2. 10 November 2020. 11 November 2020.
  291. Web site: 12 November 2020. Detection of new SARS-CoV-2 variants related to mink. 12 November 2020. ECDC.eu. European Centre for Disease Prevention and Control. 8 January 2021. https://web.archive.org/web/20210108142429/https://www.ecdc.europa.eu/sites/default/files/documents/RRA-SARS-CoV-2-in-mink-12-nov-2020.pdf. live.
  292. News: 6 November 2020. SARS-CoV-2 mink-associated variant strain – Denmark. WHO Disease Outbreak News. 19 March 2021. 12 November 2020. https://web.archive.org/web/20201112034824/https://www.who.int/csr/don/06-november-2020-mink-associated-sars-cov2-denmark/en/. dead.
  293. Web site: Kevany S, Carstensen T . Danish Covid mink variant 'very likely extinct', but controversial cull continues . The Guardian . 19 November 2020 . 19 April 2021 . 24 April 2021 . https://web.archive.org/web/20210424001442/https://www.theguardian.com/environment/2020/nov/19/danish-covid-mink-variant-very-likely-extinct-but-controversial-cull-continues . live .
  294. Larsen HD, Fonager J, Lomholt FK, Dalby T, Benedetti G, Kristensen B, Urth TR, Rasmussen M, Lassaunière R, Rasmussen TB, Strandbygaard B, Lohse L, Chaine M, Møller KL, Berthelsen AN, Nørgaard SK, Sönksen UW, Boklund AE, Hammer AS, Belsham GJ, Krause TG, Mortensen S, Bøtner A, Fomsgaard A, Mølbak K . Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020 . Euro Surveillance . 26 . 5 . February 2021 . 33541485 . 7863232 . 10.2807/1560-7917.ES.2021.26.5.210009 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Variants of SARS-CoV-2".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.